広島大学

基本情報

学位

• 博士（医学）　(神戸大学)

研究分野

• 医歯薬学 / 外科系臨床医学 / 呼吸器外科学

教育活動

授業担当

1. 2025年, 学部専門, 通年, 器官・システム病態制御学I
2. 2025年, 学部専門, 通年, 全身性疾患制御学
3. 2025年, 学部専門, 集中, 医学研究実習
4. 2025年, 学部専門, 集中, 臨床実習I
5. 2025年, 学部専門, 集中, 臨床実習II
6. 2025年, 博士課程・博士課程後期, セメスター（前期）, 腫瘍外科学特別演習
7. 2025年, 博士課程・博士課程後期, セメスター（後期）, 腫瘍外科学特別演習
8. 2025年, 博士課程・博士課程後期, セメスター（前期）, 腫瘍外科学特別研究
9. 2025年, 博士課程・博士課程後期, セメスター（後期）, 腫瘍外科学特別研究
10. 2025年, 博士課程・博士課程後期, セメスター（前期）, 乳がん治療演習
11. 2025年, 博士課程・博士課程後期, セメスター（後期）, 乳がん治療演習
12. 2025年, 博士課程・博士課程後期, セメスター（前期）, 腫瘍外科治療演習
13. 2025年, 博士課程・博士課程後期, セメスター（後期）, 腫瘍外科治療演習

研究活動

学術論文（★は代表的な論文）

1. Dual inhibition of GTP-bound KRAS and mTOR in lung adenocarcinoma and squamous cell carcinoma harboring KRAS G12C, CELL COMMUNICATION AND SIGNALING, 23巻, 1号, 20250511
   DOIを用いた論文検索結果へのリンク
2. Diversity of ER-positive and HER2-negative breast cancer stem cells attained using selective culture techniques, SCIENTIFIC REPORTS, 15巻, 1号, 20250310
   DOIを用いた論文検索結果へのリンク
3. Segmentectomy versus lobectomy in younger patients with early-stage non-small cell lung cancer, INTERDISCIPLINARY CARDIOVASCULAR AND THORACIC SURGERY, 40巻, 2号, 20250303
   DOIを用いた論文検索結果へのリンク
4. Role of guanylate-binding protein 1 in the proliferation of invasive lung adenocarcinoma cells, FRONTIERS IN ONCOLOGY, 15巻, 20250213
   DOIを用いた論文検索結果へのリンク
5. Evaluating the risk of underdiagnosis of invasive breast cancer in needle biopsy-diagnosed ductal carcinoma in situ eligible for radiofrequency ablation, WORLD JOURNAL OF SURGICAL ONCOLOGY, 23巻, 1号, 20250205
   DOIを用いた論文検索結果へのリンク
6. Exploring the possibility of omitting axillary surgery in patients with clinical node-positive breast cancer achieving ypT0 after neoadjuvant chemotherapy, BREAST CANCER RESEARCH AND TREATMENT, 212巻, 1号, pp. 47-56, 202507
   DOIを用いた論文検索結果へのリンク
7. Mediastinal lymph node dissection in segmentectomy for peripheral c-stage IA (≤2 cm) non-small-cell lung cancer, J Thorac Cardiovasc Surg, 169巻, 4号, pp. 1108-1119.e3, 202504
8. Comparative oncological features of centrally and peripherally located small-sized radiologically solid-dominant non-small-cell lung cancer, EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 67巻, 4号, 202504
   DOIを用いた論文検索結果へのリンク
9. Role of ¹⁸F-fluorodeoxyglucose accumulation in radiological ground-glass opacity of non-small cell lung cancer, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 55巻, 4号, pp. 391-398, 202504
   DOIを用いた論文検索結果へのリンク
10. CRES³T: A single-arm confirmatory trial of S-1 plus cisplatin with concurrent radical-dose radiotherapy followed by surgery for superior sulcus tumors, LUNG CANCER, 202巻, 202504
    DOIを用いた論文検索結果へのリンク
11. Thoracic and cardiovascular surgeries in Japan during 2022 Annual report by the Japanese Association for Thoracic Surgery, GENERAL THORACIC AND CARDIOVASCULAR SURGERY, 73巻, 4号, pp. 254-294, 202504
    DOIを用いた論文検索結果へのリンク
12. Risk Factors for Locoregional Relapse After Segmentectomy: Supplementary Analysis of the JCOG0802/WJOG4607L Trial, JOURNAL OF THORACIC ONCOLOGY, 20巻, 2号, pp. 157-166, 202502
    DOIを用いた論文検索結果へのリンク
13. Feasibility and comparative prognosis of segmentectomy versus lobectomy in centrally located small and solid dominant cN0 non-small cell lung cancer, JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 169巻, 2号, 202502
    DOIを用いた論文検索結果へのリンク
14. Recurrence and prognostic predictors in pathologic T1N0 esophageal squamous cell carcinoma treated with surgery alone, SURGERY, 178巻, 202502
    DOIを用いた論文検索結果へのリンク
15. ASO Author Reflections: Surgical Procedures for Early-Stage Lung Cancer Patients with Low Muscle Mass, Ann Surg Oncol, 32巻, 6号, pp. 4191-4192, 202501
16. Prediction of Pathologic Complete Response in Esophageal Squamous Cell Carcinoma Using Preoperative Serum Small Ribonucleic Acid Obtained After Neoadjuvant Chemoradiotherapy, ANNALS OF SURGICAL ONCOLOGY, 32巻, 1号, pp. 570-580, 202501
    DOIを用いた論文検索結果へのリンク
17. Omitting Lymph Node Dissection for Small Ground-Glass Opacity-Dominant Tumors, ANNALS OF THORACIC SURGERY, 119巻, 1号, pp. 192-198, 202501
    DOIを用いた論文検索結果へのリンク
18. Atezolizumab and Platinum Plus Pemetrexed With or Without Bevacizumab for Metastatic Nonsquamous Non-Small Cell Lung Cancer: A Phase 3 Randomized Clinical Trial, JAMA Oncol, 10巻, 3号, pp. 315-324, 20240301
19. Impact of Fusobacterium nucleatum in the treatment of cancer, including radiotherapy and its future potential in esophageal cancer, JOURNAL OF RADIATION RESEARCH, 65巻, pp. i126-i134, 20241216
    DOIを用いた論文検索結果へのリンク
20. Postoperative pulmonary function of patients with lung cancer and interstitial lung abnormalities, GENERAL THORACIC AND CARDIOVASCULAR SURGERY, 72巻, 12号, pp. 786-795, 20241201
    DOIを用いた論文検索結果へのリンク
21. Factors influencing decision-making between surgery and chemoradiotherapy for esophageal carcinoma from the JCOG0502, FUTURE ONCOLOGY, 20巻, 36号, pp. 2849-2854, 20241116
    DOIを用いた論文検索結果へのリンク
22. A nomogram to predict the pathological complete response in patients with breast cancer based on the TILs-US score, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 54巻, 9号, pp. 967-974, 20240612
    DOIを用いた論文検索結果へのリンク
23. Postoperative Lymph Node Recurrence in Esophageal Cancer After Surgery and Prognosis of Chemoradiotherapy, Cancer Diagn Progn, 4巻, 3号, pp. 276-280, 20240503
24. Differences in postoperative prognosis between early-stage lung adenocarcinoma and squamous cell carcinoma, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 54巻, 7号, pp. 813-821, 20240427
    DOIを用いた論文検索結果へのリンク
25. Effectiveness of pleurodesis for postoperative air leaks after lung resection, JOURNAL OF CARDIOTHORACIC SURGERY, 19巻, 1号, 20240102
    DOIを用いた論文検索結果へのリンク
26. Diagnostic performance of TILs-US score and LPBC in biopsy specimens for predicting pathological complete response in patients with breast cancer, Int J Clin Oncol, 29巻, 12号, pp. 1860-1869, 202412
27. Mitochondrial Metabolism as a Potential Novel Therapeutic Target for Lung Adenocarcinoma, ANTICANCER RESEARCH, 44巻, 12号, pp. 5241-5252, 202412
    DOIを用いた論文検索結果へのリンク
28. Reply: Tumor distance from the mediastinum as a preoperative predictor for occult mediastinal nodal metastasis, J Thorac Cardiovasc Surg, 168巻, 5号, pp. e138-e139, 202411
29. Relationship of Immune-Related Adverse Events with Tumor Response and Prognosis in Esophageal Squamous Cell Carcinoma Following Nivolumab Monotherapy, CANCERS, 16巻, 20号, 202410
    DOIを用いた論文検索結果へのリンク
30. Lymph node dissection in small peripheral lung cancer: Supplemental analysis of JCOG0802/WJOG4607L, J Thorac Cardiovasc Surg, 168巻, 3号, pp. 674-683.e1, 202409
31. Advanced Clinical Trial Chest Surgery Group. Early chest tube removal regardless of drainage volume after anatomic pulmonary resection: A multicenter, randomized, controlled trial, J Thorac Cardiovasc Surg, 168巻, 2号, pp. 401-410.e1, 202408
32. The Role of Emphysema on Postoperative Prognosis in Early-Stage Nonsmall Cell Lung Cancer, ANNALS OF SURGICAL ONCOLOGY, 31巻, 8号, pp. 5055-5063, 202408
    DOIを用いた論文検索結果へのリンク
33. Sublobar Resection in Early Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor Mutant, ANNALS OF THORACIC SURGERY, 118巻, 2号, pp. 395-401, 202408
    DOIを用いた論文検索結果へのリンク
34. ASO Author Reflections: How Does Emphysema Contribute to Poor Prognosis After Lung Cancer Surgery?, ANNALS OF SURGICAL ONCOLOGY, 31巻, 7号, pp. 4323-4324, 202407
    DOIを用いた論文検索結果へのリンク
35. Risk factors for recurrence of esophageal squamous cell carcinoma after pathological complete response to neoadjuvant therapy followed by esophagectomy, WORLD JOURNAL OF SURGERY, 48巻, 7号, pp. 1700-1709, 202407
    DOIを用いた論文検索結果へのリンク
36. Pathologic Response and Survival after Neoadjuvant Chemotherapy with Bevacizumab Followed by Surgery for Clinical Stage II/IIIA Nonsquamous Non-Small-Cell Lung Cancer: Results from a Phase II Feasibility Study (NAVAL), CANCERS, 16巻, 13号, 202407
    DOIを用いた論文検索結果へのリンク
37. Clinical Signif icance of Preserving Pulmonary Function After Lung Resection in Early-Stage Non-Small-Cell Lung Cancer, CLINICAL LUNG CANCER, 25巻, 4号, 202406
    DOIを用いた論文検索結果へのリンク
38. Cross-Correlation of Confocal Images for Excised Breast Tissues of Total Mastectomy, IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING, 71巻, 5号, pp. 1705-1716, 202405
    DOIを用いた論文検索結果へのリンク
39. Reply to "Correspondence: SPARC, HEG1, and the Diagnosis of Epithelioid Mesothelioma" by Churg et al, AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 48巻, 5号, pp. 632-634, 202405
    DOIを用いた論文検索結果へのリンク
40. Risk Factors for Recurrence of Stage I Epidermal Growth Factor Receptor Mutated Lung Adenocarcinoma, ANNALS OF THORACIC SURGERY, 117巻, 4号, 202404
    DOIを用いた論文検索結果へのリンク
41. Second-line tislelizumab versus chemotherapy in Japanese patients with advanced or metastatic esophageal squamous cell carcinoma: subgroup analysis from RATIONALE-302, ESOPHAGUS, 21巻, 2号, pp. 102-110, 202404
    DOIを用いた論文検索結果へのリンク
42. Thoracic and cardiovascular surgeries in Japan during 2021Annual report by the Japanese Association for Thoracic Surgery, GENERAL THORACIC AND CARDIOVASCULAR SURGERY, 72巻, 4号, pp. 254-291, 202404
    DOIを用いた論文検索結果へのリンク
43. Association between prognosis and lymph node status using ¹⁸F-fluorodeoxyglucose-positron emission tomography in esophageal squamous cell carcinoma treated with esophagectomy post-neoadjuvant chemotherapy, WORLD JOURNAL OF SURGERY, 48巻, 3号, pp. 650-661, 202403
    DOIを用いた論文検索結果へのリンク
44. Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer with radiologically pure-solid appearance in Japan (JCOG0802/WJOG4607L): a post-hoc supplemental analysis of a multicentre, open-label, phase 3 trial, LANCET RESPIRATORY MEDICINE, 12巻, 2号, pp. 105-116, 202402
    DOIを用いた論文検索結果へのリンク
45. Tumor distance from the mediastinum predicts N2 upstaging in clinical stage I lower-lobe non-small cell lung cancer, JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 167巻, 2号, 202402
    DOIを用いた論文検索結果へのリンク
46. NOTCH1 and CREBBP co-mutations negatively affect the benefit of adjuvant therapy in completely resected EGFR-mutated NSCLC: translational research of phase III IMPACT study, MOLECULAR ONCOLOGY, 18巻, 2号, pp. 305-316, 202402
    DOIを用いた論文検索結果へのリンク
47. Prognostic factors for esophageal squamous cell carcinoma without pathological lymph node metastasis after neoadjuvant therapy and surgery, WORLD JOURNAL OF SURGERY, 48巻, 2号, pp. 416-426, 202402
    DOIを用いた論文検索結果へのリンク
48. Neoadjuvant nivolumab plus chemotherapy in resectable non-small-cell lung cancer in Japanese patients from CheckMate 816, CANCER SCIENCE, 115巻, 2号, pp. 540-554, 202402
    DOIを用いた論文検索結果へのリンク
49. SPARC Is a Novel Positive Immunohistochemical Marker of Epithelioid Mesothelioma to Differentiate It From Lung Adenocarcinoma and/or Squamous Cell Carcinoma, AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 48巻, 2号, pp. 140-149, 202402
    DOIを用いた論文検索結果へのリンク
50. The treatment efficacy and prognosis of each treatment in early postoperative recurrence of esophageal squamous cell carcinoma, SURGERY TODAY, 54巻, 1号, pp. 53-63, 202401
    DOIを用いた論文検索結果へのリンク
51. Thoracic and cardiovascular surgeries in Japan during 2020: Annual report by the Japanese Association for Thoracic Surgery, GENERAL THORACIC AND CARDIOVASCULAR SURGERY, 72巻, 1号, pp. 61-94, 202401
    DOIを用いた論文検索結果へのリンク
52. Discrepancy Between Radiological and Pathological Tumor Size in Early-Stage Non-Small Cell Lung Cancer: A Multicenter Study, Semin Thorac Cardiovasc Surg, 36巻, 2号, pp. 273-281, 2024
53. Clinicopathologic study of stage I adenosquamous carcinoma of the lung, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 53巻, 12号, pp. 1201-1207, 20231207
    DOIを用いた論文検索結果へのリンク
54. A multicenter propensity score-matched analysis of lymphadenectomy in N1-positve lung cancer, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 53巻, 12号, pp. 1183-1190, 20231207
    DOIを用いた論文検索結果へのリンク
55. Risk factors for loss of pulmonary function after wedge resection for peripheral ground-glass opacity dominant lung cancer, EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 64巻, 6号, 20231201
    DOIを用いた論文検索結果へのリンク
56. Hypoxia-inducible factor 1alpha modulates interstitial pneumonia-mediated lung cancer progression, J Transl Med, 21巻, 1号, pp. 857-1892, 20231127
57. Hypoxia-inducible factor 1ﾎｱ modulates interstitial pneumonia-mediated lung cancer progression, JOURNAL OF TRANSLATIONAL MEDICINE, 21巻, 1号, 20231127
    DOIを用いた論文検索結果へのリンク
58. Lymph node dissection in small peripheral lung cancer: Supplemental analysis of JCOG0802/WJOG4607L, J Thorac Cardiovasc Surg, S0022-5223巻, 23号, pp. 01099-1-1892, 20231123
59. Preoperative predictors for recurrence sites associated with poor post-recurrence survival after surgery of non-small cell lung cancer: a multicenter study, BMC CANCER, 23巻, 1号, 20231106
    DOIを用いた論文検索結果へのリンク
60. Anatomical segmentectomy versus wedge resection for small (≤2 cm) peripheral non -small cell lung cancer in 80 or more aged elderly patients: a randomized phase Ill study (JCOG2109, AWESOME), JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 53巻, 11号, pp. 1077-1081, 20231105
    DOIを用いた論文検索結果へのリンク
61. Segmentectomy for cancer control in radiologically pure-solid clinical stage IA3 lung cancer, INTERDISCIPLINARY CARDIOVASCULAR AND THORACIC SURGERY, 37巻, 3号, 20230902
    DOIを用いた論文検索結果へのリンク
62. Wedge resection vs. segmentectomy for lung cancer measuring ≤ 2 cm with consolidation tumor ratio > 0.25, FRONTIERS IN ONCOLOGY, 13巻, 20230828
    DOIを用いた論文検索結果へのリンク
63. Reply to Zhou and Yu, Eur J Cardiothorac Surg, 63巻, 6号, pp. ezad195-1892, 20230601
64. Reply to Zhou and Yu, EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 63巻, 6号, 20230601
    DOIを用いた論文検索結果へのリンク
65. FOXA2 Cooperates with Mutant KRAS to Drive Invasive Mucinous Adenocarcinoma of the Lung, CANCER RESEARCH, 83巻, 9号, pp. 1443-1458, 20230501
    DOIを用いた論文検索結果へのリンク
66. Extracellular vesicle-associated microRNA signatures related to lymphovascular invasion in early-stage lung adenocarcinoma, SCIENTIFIC REPORTS, 13巻, 1号, 20230424
    DOIを用いた論文検索結果へのリンク
67. Real-world clinical outcomes of nivolumab and taxane as a second- or later-line therapy for recurrent or unresectable advanced esophageal squamous cell carcinoma, FRONTIERS IN ONCOLOGY, 13巻, 20230417
    DOIを用いた論文検索結果へのリンク
68. The efficacy of thoracoscopic surgery for descending necrotizing mediastinitis, INTERDISCIPLINARY CARDIOVASCULAR AND THORACIC SURGERY, 36巻, 4号, 20230403
    DOIを用いた論文検索結果へのリンク
69. Extracellular vesicle-associated microRNA signatures related to lymphovascular invasion in early-stage lung adenocarcinoma, SCIENTIFIC REPORTS, 13巻, 1号, 20230324
    DOIを用いた論文検索結果へのリンク
70. Distribution and prognostic impact of EGFR and KRAS mutations according to histological subtype and tumor invasion status in pTis-3N0M0 lung adenocarcinoma, BMC CANCER, 23巻, 1号, 20230314
    DOIを用いた論文検索結果へのリンク
71. Reply to Sanz-Santos et al, EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 63巻, 3号, 20230301
    DOIを用いた論文検索結果へのリンク
72. Segmentectomy preserves better immune-nutritional status than lobectomy in patients with early-stage lung cancer, EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 63巻, 2号, 20230203
    DOIを用いた論文検索結果へのリンク
73. Tumour location predicts occult N1 nodal metastasis in clinical stage I non-small-cell lung cancer, EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 63巻, 2号, 20230203
    DOIを用いた論文検索結果へのリンク
74. Wedge resection is an acceptable treatment option for radiologically low-grade lung cancer with solid predominance, INTERDISCIPLINARY CARDIOVASCULAR AND THORACIC SURGERY, 36巻, 1号, 20230109
    DOIを用いた論文検索結果へのリンク
75. Lack of Association of Plasma Levels of Soluble Programmed Cell Death Protein 1, Programmed Death-Ligand 1, and CTLA-4 With Survival for Stage II to IIIA NSCLC After Complete Resection and Adjuvant Chemotherapy, JTO CLINICAL AND RESEARCH REPORTS, 4巻, 12号, 202312
    DOIを用いた論文検索結果へのリンク
76. Musashi-1 Is a Novel Immunohistochemical Marker of Neuroendocrine Carcinoma of the Lung, CANCERS, 15巻, 23号, 202312
    DOIを用いた論文検索結果へのリンク
77. Asian Perspective on Lung Cancer Screening, THORACIC SURGERY CLINICS, 33巻, 4号, pp. 385-400, 202311
    DOIを用いた論文検索結果へのリンク
78. Thoracic and cardiovascular surgeries in Japan during 2019 Annual report by the Japanese Association for Thoracic Surgery, GENERAL THORACIC AND CARDIOVASCULAR SURGERY, 71巻, 10号, pp. 595-628, 202310
    DOIを用いた論文検索結果へのリンク
79. Long-term outcome of patients with peripheral ground-glass opacity-dominant lung cancer after sublobar resections, JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 166巻, 4号, pp. 1222-+, 202310
    DOIを用いた論文検索結果へのリンク
80. Segmentectomy and Wedge Resection Should Be Distinguished as Sublobar Resections for Lung Cancer, Ann Thorac Surg, 116巻, 4号, pp. 859, 202310
81. Risk factors for aortoesophageal fistula in cT4b esophageal squamous cell carcinoma after definitive radiation therapy, JOURNAL OF THORACIC DISEASE, 15巻, 10号, pp. 5319-5329, 202310
    DOIを用いた論文検索結果へのリンク
82. Early chest tube removal regardless of drainage volume after anatomic pulmonary resection: A multicenter, randomized, controlled trial, Thorac Cardiovasc Surg, S0022-5223巻, 23号, pp. 01007-3, 202310
83. Sublobar Resection for Non-Small Cell Lung Cancer in Octogenarians: A Prospective, Multicenter Study, ANNALS OF THORACIC SURGERY, 116巻, 3号, pp. 543-551, 202309
    DOIを用いた論文検索結果へのリンク
84. Pembrolizumab plus chemotherapy in Japanese patients with metastatic squamous non-small-cell lung cancer in KEYNOTE-407, CANCER SCIENCE, 114巻, 8号, pp. 3330-3341, 202308
    DOIを用いた論文検索結果へのリンク
85. Prospective, Multi-Institutional Observational Study of Deterioration in Activities of Daily Living in Elderly Patients After Lung Cancer Surgery, JTO CLINICAL AND RESEARCH REPORTS, 4巻, 8号, 202308
    DOIを用いた論文検索結果へのリンク
86. The Efficacy of PCSK9 Inhibitors in Treating Hypercholesterolemia Caused by Lorlatinib: A Report of Two Cases., CLINICAL LUNG CANCER, 24巻, 5号, pp. e176-e178, 202307
    DOIを用いた論文検索結果へのリンク
87. Esophageal Neuroendocrine Carcinoma With Pathological Complete Response After Neoadjuvant Chemotherapy Followed by Robot-assisted Surgery: A Case Report, ANTICANCER RESEARCH, 43巻, 7号, pp. 3289-3293, 202307
    DOIを用いた論文検索結果へのリンク
88. Segmentectomy for ground-glass-dominant lung cancer with a tumour diameter of 3 cm or less including ground-glass opacity (JCOG1211): a multicentre, single-arm, confirmatory, phase 3 trial, Lancet Respir Med, 11巻, 6号, pp. 540-549, 202306
89. Segmentectomy for ground-glass-dominant lung cancer with a tumour diameter of 3 cm or less including ground- glass opacity (JCOG1211): a multicentre, single-arm, confirmatory, phase 3 trial, LANCET RESPIRATORY MEDICINE, 11巻, 6号, pp. 540-549, 202306
    DOIを用いた論文検索結果へのリンク
90. Current clinical trials with non-coding RNA-based therapeutics in malignant diseases: A systematic review, TRANSLATIONAL ONCOLOGY, 31巻, 202305
    DOIを用いた論文検索結果へのリンク
91. First-line nivolumab plus ipilimumab or chemotherapy versus chemotherapy alone in advanced esophageal squamous cell carcinoma: a Japanese subgroup analysis of open-label, phase 3 trial (CheckMate 648/ONO-4538-50), ESOPHAGUS, 20巻, 2号, pp. 291-301, 202304
    DOIを用いた論文検索結果へのリンク
92. Effectiveness of taxanes following nivolumab in patients with advanced esophageal squamous cell carcinoma: a retrospective chart review of patients in ATTRACTION-3, ESOPHAGUS, 20巻, 2号, pp. 302-308, 202304
    DOIを用いた論文検索結果へのリンク
93. Feasibility of repeated ipsilateral anatomical pulmonary resection, SURGERY TODAY, 53巻, 3号, pp. 379-385, 202303
    DOIを用いた論文検索結果へのリンク
94. Complications and Survival After Lung Cancer Resection in Interstitial Lung Disease, Ann Thorac Surg, 115巻, 3号, pp. 701-708, 202303
95. Long-term results of chemoradiotherapy with elective nodal irradiation for resectable locally advanced esophageal cancer in three-dimensional planning system, INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 28巻, 3号, pp. 382-391, 202303
    DOIを用いた論文検索結果へのリンク
96. Usefulness of serum S100A4 and positron-emission tomography on lung cancer accompanied by interstitial pneumonia, THORACIC CANCER, 14巻, 4号, pp. 381-388, 202302
    DOIを用いた論文検索結果へのリンク
97. Association between Plasminogen Activator Inhibitor-1 and Osimertinib Tolerance in EGFR-Mutated Lung Cancer via Epithelial-Mesenchymal Transition, CANCERS, 15巻, 4号, 202302
    DOIを用いた論文検索結果へのリンク
98. Impact of oral hygiene on febrile neutropenia during breast cancer chemotherapy, BREAST CANCER, 30巻, 1号, pp. 151-155, 202301
    DOIを用いた論文検索結果へのリンク
99. [Dawn of Radical Segmentectomy for Small Sized Peripheral Non-small Cell Lung Cancer]., Kyobu Geka, 76巻, 1号, pp. 4-8, 202301
100. 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Predicts Tumor Immune Microenvironment Function in Early Triple-negative Breast Cancer, ANTICANCER RESEARCH, 43巻, 1号, pp. 127-136, 202301
     DOIを用いた論文検索結果へのリンク
101. Ability of Blood Cell Parameters to Predict Clinical Outcomes of Nivolumab Monotherapy in Advanced Esophageal Squamous Cell Carcinoma, ONCOTARGETS AND THERAPY, 16巻, pp. 263-273, 2023
     DOIを用いた論文検索結果へのリンク
102. Blood biomarkers as predictors of pathological lymph node metastasis in clinical stage T1N0 esophageal squamous cell carcinoma, DISEASES OF THE ESOPHAGUS, 36巻, 1号, 20221231
     DOIを用いた論文検索結果へのリンク
103. Advanced Clinical Trial Chest Surgery Group (ACTG).S-1 + Cisplatin with Concurrent Radiotherapy Followed by Surgery for Stage IIIA (N2) Lung Squamous Cell Carcinoma: Results of a Phase II Trial, Ann Surg Oncol, 29巻, 13号, pp. 8198-8206, 20221229
104. Discrepancy Between Radiological and Pathological Tumor Size in Early-Stage Non-Small Cell Lung Cancer: A Multicenter Study, Semin Thorac Cardiovasc Surg, S1043-0679巻, 22号, pp. 00277-5, 20221210
105. Impact of the amount of preoperative erector spinae muscle in stage I non-small-cell lung cancer, EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 63巻, 1号, 20221202
     DOIを用いた論文検索結果へのリンク
106. Prevalence of immune-related adverse events and anti-tumor efficacy following immune checkpoint inhibitor therapy in Japanese patients with various solid tumors, BMC CANCER, 22巻, 1号, 20221129
     DOIを用いた論文検索結果へのリンク
107. First-line nivolumab plus ipilimumab or chemotherapy versus chemotherapy alone in advanced esophageal squamous cell carcinoma: a Japanese subgroup analysis of open-label, phase 3 trial (CheckMate 648/ONO-4538-50), ESOPHAGUS, 20巻, 2号, pp. 291-301, 20221119
     DOIを用いた論文検索結果へのリンク
108. Phase I Study of Tremelimumab Monotherapy or in Combination With Durvalumab in Japanese Patients With Advanced Solid Tumors or Malignant Mesothelioma, ONCOLOGIST, 27巻, 9号, pp. E703-E722, 20220902
     DOIを用いた論文検索結果へのリンク
109. The prognostic impact of the ground-glass opacity component in nearly pure-solid stage IA non-small-cell lung cancer, EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 62巻, 3号, 20220803
     DOIを用いた論文検索結果へのリンク
110. Three-Year Follow-Up and Response-Survival Relationship of Nivolumab in Previously Treated Patients with Advanced Esophageal Squamous Cell Carcinoma (ATTRACTION-3), CLINICAL CANCER RESEARCH, 28巻, 15号, 20220801
     DOIを用いた論文検索結果へのリンク
111. Possible Therapeutic Utility of anti-Cell Adhesion Molecule 1 Antibodies for Malignant Pleural Mesothelioma, FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 10巻, 20220712
     DOIを用いた論文検索結果へのリンク
112. Oncological outcome of segmentectomy for early-stage non-small-cell lung cancer with invasive characteristics: a multicentre study, EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 62巻, 2号, 20220711
     DOIを用いた論文検索結果へのリンク
113. Interstitial pneumonia and advanced age negatively influence postoperative pulmonary function, INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 34巻, 5号, pp. 753-759, 20220502
     DOIを用いた論文検索結果へのリンク
114. Segmentectomy versus wedge resection for radiological solid predominant and low metabolic non-small cell lung cancer, INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 34巻, 5号, pp. 814-821, 20220502
     DOIを用いた論文検索結果へのリンク
115. Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L) : a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial, LANCET, 399巻, 10335号, pp. 1607-1617, 20220423
116. The ratio of CD8+lymphocytes to tumor-infiltrating suppressive FOXP3+effector regulatory T cells is associated with treatment response in invasive breast cancer, DISCOVER ONCOLOGY, 13巻, 1号, 20220419
     DOIを用いた論文検索結果へのリンク
117. Commentary: Segmentectomy as a standard surgery, a new era in small sized, peripheral, non-small cell lung cancer, JTCVS Tech, 20巻, 12号, pp. 210-211, 20220220
118. Segmentectomy versus lobectomy for solid predominant cN0 lung cancer: analysis using visual evaluation of positron emission tomography, EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 61巻, 2号, pp. 279-286, 20220124
     DOIを用いた論文検索結果へのリンク
119. Malignant prediction of incidental findings using ring-type dedicated breast positron emission tomography, SCIENTIFIC REPORTS, 12巻, 1号, 20220121
     DOIを用いた論文検索結果へのリンク
120. Randomized Phase III Study of Gefitinib Versus Cisplatin Plus Vinorelbine for Patients With Resected Stage II-IIIA Non-Small-Cell Lung Cancer With EGFR Mutation (IMPACT), JOURNAL OF CLINICAL ONCOLOGY, 40巻, 3号, pp. 231-+, 20220120
     DOIを用いた論文検索結果へのリンク
121. Randomized, Double-Blind, Phase III Study of Fosnetupitant Versus Fosaprepitant for Prevention of Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting: CONSOLE, JOURNAL OF CLINICAL ONCOLOGY, 40巻, 2号, pp. 180-+, 20220110
     DOIを用いた論文検索結果へのリンク
122. Risk factors for recurrence of stage I epidermal growth factor receptor mutated lung adenocarcinoma, Ann Thorac Surg, 49巻, 13号, pp. 1891-1892, 202212
123. ASO Visual Abstract: S-1+Cisplatin with Concurrent Radiotherapy Followed by Surgery for Stage IIIA (N2) Lung Squamous Cell Carcinoma: Results of a Phase II Trial, ANNALS OF SURGICAL ONCOLOGY, 29巻, 13号, pp. 8209-8210, 202212
     DOIを用いた論文検索結果へのリンク
124. Effectiveness of taxanes following nivolumab in patients with advanced esophageal squamous cell carcinoma: a retrospective chart review of patients in ATTRACTION-3, ESOPHAGUS, 202212
     DOIを用いた論文検索結果へのリンク
125. Effect of Secondary Prophylactic G-CSF on the Occurrence of Febrile Neutropenia in Breast Cancer, ANTICANCER RESEARCH, 42巻, 12号, pp. 5945-5949, 202212
     DOIを用いた論文検索結果へのリンク
126. Correlation Between Tumor Uptake on FDG-PET and Malignant Features in Esophageal Squamous Cell Carcinoma After Neoadjuvant Chemotherapy Followed by Surgery, ANTICANCER RESEARCH, 42巻, 12号, pp. 6037-6045, 202212
     DOIを用いた論文検索結果へのリンク
127. The intersegmental pulmonary vein is not always located on the intersegmental plane of the lung: Evaluation with 3-dimensional volume-rendering image reconstruction, JTCVS TECHNIQUES, 16巻, pp. 132-138, 202212
     DOIを用いた論文検索結果へのリンク
128. Adjuvant atezolizumab in Japanese patients with resected stage IB-IIIA non-small cell lung cancer (IMpower010), CANCER SCIENCE, 113巻, 12号, pp. 4327-4338, 202212
     DOIを用いた論文検索結果へのリンク
129. Segmentectomy for clinically early-stage primary squamous cell carcinoma of the lung, THORACIC CANCER, 13巻, 24号, pp. 3477-3485, 202212
     DOIを用いた論文検索結果へのリンク
130. Leukocyte Telomeric G-Tail Length Shortening Is Associated with Esophageal Cancer Recurrence, JOURNAL OF CLINICAL MEDICINE, 11巻, 24号, 202212
     DOIを用いた論文検索結果へのリンク
131. S-1+Cisplatin with Concurrent Radiotherapy Followed by Surgery for Stage IIIA (N2) Lung Squamous Cell Carcinoma: Results of a Phase II Trial, ANNALS OF SURGICAL ONCOLOGY, 29巻, 13号, pp. 8198-8206, 202212
     DOIを用いた論文検索結果へのリンク
132. Segmentectomy for Spread Through Air Spaces-positive Lung Adenocarcinoma, Ann Thorac Surg, 114巻, 5号, pp. 1989-1990, 202211
133. The impact of epidermal growth factor receptor mutation status on adjuvant chemotherapy for patients with high-risk stage I lung adenocarcinoma, J Thorac Cardiovasc Surg, 164巻, 5号, pp. 1306-1315.e4, 202211
134. Committee for Scientific Affairs, The Japanese Association for Chest Surgery. The C-reactive protein to albumin ratio is a prognostic factor for stage I non-small cell lung cancer in elderly patients: JACS1303, Surg Today, 52巻, 10号, pp. 1463-1471, 202210
135. The tumor-infiltrating lymphocyte ultrasonography score can provide a diagnostic prediction of lymphocyte-predominant breast cancer preoperatively, JOURNAL OF MEDICAL ULTRASONICS, 49巻, 4号, pp. 709-717, 202210
     DOIを用いた論文検索結果へのリンク
136. The C-reactive protein to albumin ratio is a prognostic factor for stage I non-small cell lung cancer in elderly patients: JACS1303, SURGERY TODAY, 52巻, 10号, pp. 1463-1471, 202210
     DOIを用いた論文検索結果へのリンク
137. Dual-phase FDG PET/CT for predicting prognosis in operable breast cancer, BREAST, 65巻, pp. 98-103, 202210
     DOIを用いた論文検索結果へのリンク
138. Randomized phase II trial of pemetrexed-cisplatin plus bevacizumab or thoracic radiotherapy followed by surgery for stage IIIA (N2) nonsquamous non-small cell lung cancer, JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 164巻, 3号, pp. 661-+, 202209
     DOIを用いた論文検索結果へのリンク
139. Prognostic value of quantitative parameters for esophageal squamous cell carcinoma determined by preoperative FDG-PET after trimodal therapy, SURGERY, 172巻, 2号, pp. 584-592, 202208
     DOIを用いた論文検索結果へのリンク
140. Evaluation of Neoadjuvant Chemoradiotherapy Followed by Surgery for Borderline Resectable Esophageal Squamous Cell Carcinoma, WORLD JOURNAL OF SURGERY, 46巻, 8号, pp. 1934-1943, 202208
     DOIを用いた論文検索結果へのリンク
141. Psychological states regarding adjuvant chemotherapy in patients with non-small cell lung cancer, Cancer Treat Res Commun, 23巻, 5号, pp. 393-401, 202207
142. A Multicenter Study of Complex Segmentectomy Versus Wedge Resection in Clinical Stage 0-IA Non-Small Cell Lung Cancer, CLINICAL LUNG CANCER, 23巻, 5号, pp. 393-401, 202207
     DOIを用いた論文検索結果へのリンク
143. Neoadjuvant pemetrexed plus cisplatin followed by pleurectomy for malignant pleural mesothelioma, JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 163巻, 6号, pp. 1940-+, 202206
     DOIを用いた論文検索結果へのリンク
144. Exploratory Analysis Comparing Fosnetupitant Versus Fosaprepitant for Prevention of Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting (CINV): A Randomized, Double-Blind, Phase 3 Study (CONSOLE), ONCOLOGY AND THERAPY, 10巻, 1号, pp. 253-262, 202206
     DOIを用いた論文検索結果へのリンク
145. Sensitivity and optimal clinicopathological features for mutation-targeted liquid biopsy in pN0M0 EGFR-mutant lung adenocarcinoma, JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 148巻, 6号, pp. 1419-1428, 202206
     DOIを用いた論文検索結果へのリンク
146. Role of ground-glass opacity in pure invasive and lepidic component in pure solid lung adenocarcinoma for predicting aggressiveness, JTCVS Open, 2巻, 11号, pp. 300-316, 202205
147. Adjuvant Chemotherapy for High-risk Pathologic Stage I Non-Small Cell Lung Cancer, ANNALS OF THORACIC SURGERY, 113巻, 5号, pp. 1608-1616, 202205
     DOIを用いた論文検索結果へのリンク
148. Role of Soluble Receptor for Advanced Glycation End Products in Postoperative Fibrotic Lung Injury, ANNALS OF THORACIC SURGERY, 113巻, 5号, pp. 1617-1623, 202205
     DOIを用いた論文検索結果へのリンク
149. The TILs-US score on ultrasonography can predict the pathological response to neoadjuvant chemotherapy for human epidermal growth factor receptor 2-positive and triple-negative breast cancer, SURGICAL ONCOLOGY-OXFORD, 41巻, 202205
     DOIを用いた論文検索結果へのリンク
150. Clinical Outcomes of Esophagectomy and Chemoradiotherapy After Endoscopic Resection for Superficial Esophageal Squamous Cell Carcinoma, ANTICANCER RESEARCH, 42巻, 5号, pp. 2791-2795, 202205
     DOIを用いた論文検索結果へのリンク
151. Prognostic Impact of Mediastinal Lymph Node Dissection in Octogenarians With Lung Cancer: JACS1303, CLINICAL LUNG CANCER, 23巻, 3号, pp. E176-E184, 202205
     DOIを用いた論文検索結果へのリンク
152. Complex Segmentectomy for Hypermetabolic Clinical Stage IA Non-Small Cell Lung Cancer, ANNALS OF THORACIC SURGERY, 113巻, 4号, pp. 1317-1324, 202204
     DOIを用いた論文検索結果へのリンク
153. Japanese Current Status of Curative-Intent Surgery for Malignant Pleural Mesothelioma, ANNALS OF THORACIC SURGERY, 113巻, 4号, pp. 1348-1353, 202204
     DOIを用いた論文検索結果へのリンク
154. Recurrent esophageal adenocarcinoma derived from ectopic gastric mucosa: A case report, THORACIC CANCER, 13巻, 6号, pp. 876-879, 202203
     DOIを用いた論文検索結果へのリンク
155. Neutrophil-to-Lymphocyte Ratio as a Predictor of Postoperative Recurrence and Prognosis in Oesophageal Squamous Cell Carcinoma, ANTICANCER RESEARCH, 42巻, 3号, pp. 1499-1507, 202203
     DOIを用いた論文検索結果へのリンク
156. Prognostic biomarker study in patients with clinical stage I esophageal squamous cell carcinoma: JCOG0502-A1, CANCER SCIENCE, 113巻, 3号, pp. 1018-1027, 202203
     DOIを用いた論文検索結果へのリンク
157. Bevacizumab plus erlotinib versus erlotinib alone in Japanese patients with advanced, metastatic, EGFR-mutant non-small-cell lung cancer (NEJ026): overall survival analysis of an open-label, randomised, multicentre, phase 3 trial, LANCET RESPIRATORY MEDICINE, 10巻, 1号, pp. 72-82, 202201
     DOIを用いた論文検索結果へのリンク
158. Preoperative Cumulative Smoking Dose on Lung Cancer Surgery in a Japanese Nationwide Database, ANNALS OF THORACIC SURGERY, 113巻, 1号, pp. 237-243, 202201
     DOIを用いた論文検索結果へのリンク
159. A risk model for prolonged air leak after lobectomy using the National Clinical Database in Japan, SURGERY TODAY, 52巻, 1号, pp. 69-74, 202201
     DOIを用いた論文検索結果へのリンク
160. p Clinical Behavior of Combined Versus Pure High-Grade Neuroendocrine Carcinoma, CLINICAL LUNG CANCER, 23巻, 1号, pp. E9-+, 202201
     DOIを用いた論文検索結果へのリンク
161. Psychological states regarding adjuvant chemotherapy in patients with non-small cell lung cancer, CANCER TREATMENT AND RESEARCH COMMUNICATIONS, 32巻, 2022
     DOIを用いた論文検索結果へのリンク
162. Prognostic Factors for Patients With Esophageal Squamous Cell Carcinoma After Neoadjuvant Chemotherapy Followed by Surgery, IN VIVO, 36巻, 6号, pp. 2852-2860, 2022
     DOIを用いた論文検索結果へのリンク
163. Clinicopathologic Features and Response to Therapy of NRG1 Fusion-Driven Lung Cancers: The eNRGy1 Global Multicenter Registry, JOURNAL OF CLINICAL ONCOLOGY, 39巻, 25号, pp. 2791-+, 20210901
     DOIを用いた論文検索結果へのリンク
164. Clinical Behavior of Combined Versus Pure High-Grade Neuroendocrine Carcinoma., Clin Lung Cancer, 20210704
165. Sensitivity and optimal clinicopathological features for mutation-targeted liquid biopsy in pN0M0 EGFR-mutant lung adenocarcinoma., J Cancer Res Clin Oncol, 20210703
166. Identification of High-Risk of Recurrence in Clinical Stage I Non-Small Cell Lung Cancer, FRONTIERS IN ONCOLOGY, 11巻, 20210607
     DOIを用いた論文検索結果へのリンク
167. Serum S100 calcium-binding protein A4 as a novel predictive marker of acute exacerbation of interstitial pneumonia after surgery for lung cancer, BMC PULMONARY MEDICINE, 21巻, 1号, 20210602
     DOIを用いた論文検索結果へのリンク
168. Is Wedge Resection Optimal for Octogenarians with Early-Stage Non-Small-Cell Lung Cancer Compared with Lobectomy/Segmentectomy?, Ann Surg Oncol, 20210523
169. Complex Segmentectomy for Hypermetabolic Clinical Stage IA Non-Small Cell Lung Cancer., Ann Thorac Surg, 20210520
170. Clinical effect of the pathological axillary assessment method in breast cancer without clinical nodal metastasis., Breast Cancer, 20210519
171. Preoperative nivolumab to evaluate pathological response in patients with stage I non-small cell lung cancer: a study protocol of phase II trial (POTENTIAL)., BMJ Open, 20210517
172. Predictive role of circulatory HMGB1 in postoperative acute exacerbation of interstitial lung disease in lung cancer patients, SCIENTIFIC REPORTS, 11巻, 1号, 20210512
     DOIを用いた論文検索結果へのリンク
173. Surgical challenges in multimodal treatment of N2-stage IIIA non-small cell lung cancer., Jpn J Clin Oncol, 20210503
174. Breast cancer detection by dedicated breast positron emission tomography according to the World Health Organization classification of breast tumors., Eur J Surg Oncol, 20210503
175. Transition of Treatment for Ground Glass Opacity-Dominant Non-Small Cell Lung Cancer, FRONTIERS IN ONCOLOGY, 11巻, 20210415
     DOIを用いた論文検索結果へのリンク
176. Bronchial mucosal ablation for bronchial stump closure in right pneumonectomy: a case report., J Med Case Rep, 20210218
177. Bronchial mucosal ablation for bronchial stump closure in right pneumonectomy: a case report, JOURNAL OF MEDICAL CASE REPORTS, 15巻, 1号, 20210218
     DOIを用いた論文検索結果へのリンク
178. Preoperative cumulative smoking dose on lung cancer surgery in a Japanese nationwide database., Ann Thorac Surg, 20210215
179. Certified thoracic surgeons in Japan: a national database survey on risk-adjusted mortality associated with lung resection., Surg Today, 20210130
180. Performance of dedicated breast positron emission tomography in the detection of small and low-grade breast cancer., Breast Cancer Res Treat, 20210123
181. A phase II study of cisplatin plus vinorelbine combined with atezolizumab as adjuvant therapy for completely resected non-small-cell lung cancer with EGFR mutation (West Japan Oncology Group 11719L/ADJUST study)., Ther Adv Med Oncol, 20210121
182. Salvage surgery for non-small cell lung cancer after tyrosine kinase inhibitor treatment., Lung Cancer, 20210110
183. Descending necrotizing mediastinitis and the proposal of a new classification, JTCVS OPEN, 8巻, pp. 633-647, 202112
     DOIを用いた論文検索結果へのリンク
184. ASO Author Reflection: Position of the Complex Segmentectomy on Postoperative Pulmonary Function, ANNALS OF SURGICAL ONCOLOGY, 28巻, 13号, pp. 8356-8357, 202112
     DOIを用いた論文検索結果へのリンク
185. Comprehensive analysis of the clinicopathological features, targetable profile, and prognosis of mucinous adenocarcinoma of the lung, JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 147巻, 12号, pp. 3709-3718, 202112
     DOIを用いた論文検索結果へのリンク
186. Postoperative Pulmonary Function After Complex Segmentectomy, ANNALS OF SURGICAL ONCOLOGY, 28巻, 13号, pp. 8347-8355, 202112
     DOIを用いた論文検索結果へのリンク
187. Parallel-Group Controlled Trial of Surgery Versus Chemoradiotherapy in Patients With Stage I Esophageal Squamous Cell Carcinoma, GASTROENTEROLOGY, 161巻, 6号, pp. 1878-+, 202112
     DOIを用いた論文検索結果へのリンク
188. Pathological high malignant grade is higher risk of recurrence in pN0M0 invasive lung adenocarcinoma, even with small invasive size, THORACIC CANCER, 12巻, 23号, pp. 3141-3149, 202112
     DOIを用いた論文検索結果へのリンク
189. Prospective Randomized Trial of Early Postoperative Enteral and Total Parenteral Nutrition for Treating Esophageal Cancer, ANTICANCER RESEARCH, 41巻, 12号, pp. 6237-6246, 202112
     DOIを用いた論文検索結果へのリンク
190. ASO Author Reflections: Is Wedge Resection Optimal for Octogenarians with Early-Stage Non-Small-Cell Lung Cancer Compared with Lobectomy/Segmentectomy?, ANNALS OF SURGICAL ONCOLOGY, 28巻, 12号, pp. 7228-7229, 202111
     DOIを用いた論文検索結果へのリンク
191. Survival of Octogenarians with Early-Stage Non-small Cell Lung Cancer is Comparable Between Wedge Resection and Lobectomy/Segmentectomy: JACS1303, ANNALS OF SURGICAL ONCOLOGY, 28巻, 12号, pp. 7219-7227, 202111
     DOIを用いた論文検索結果へのリンク
192. Systematic Versus Lobe-Specific Mediastinal Lymphadenectomy for Hypermetabolic Lung Cancer, ANNALS OF SURGICAL ONCOLOGY, 28巻, 12号, pp. 7162-7171, 202111
     DOIを用いた論文検索結果へのリンク
193. Phase II Study of Neoadjuvant Concurrent Chemo-immuno-radiation Therapy Followed by Surgery and Adjuvant Immunotherapy for Resectable Stage IIIA-B (Discrete N2) Non-small-cell Lung Cancer: SQUAT trial 12119L), CLINICAL LUNG CANCER, 22巻, 6号, pp. 596-600, 202111
     DOIを用いた論文検索結果へのリンク
194. Risk of death due to other causes is lower among octogenarians with non-small cell lung cancer after wedge resection than lobectomy/segmentectomy, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 51巻, 10号, pp. 1561-1569, 202110
     DOIを用いた論文検索結果へのリンク
195. Comparison of cancer control between segmentectomy and wedge resection in patients with clinical stage IA non-small cell lung cancer, JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 162巻, 4号, pp. 1244-+, 202110
     DOIを用いた論文検索結果へのリンク
196. Clinical effect of the pathological axillary assessment method in breast cancer without clinical nodal metastasis, BREAST CANCER, 28巻, 5号, pp. 1016-1022, 202109
     DOIを用いた論文検索結果へのリンク
197. Meta-analysis of nanoparticle albumin-bound paclitaxel used as neoadjuvant chemotherapy for operable breast cancer based on individual patient data (JBCRG-S01 study), BREAST CANCER, 28巻, 5号, pp. 1023-1037, 202109
     DOIを用いた論文検索結果へのリンク
198. Effect of Wnt5a on drug resistance in estrogen receptor-positive breast cancer, BREAST CANCER, 28巻, 5号, pp. 1062-1071, 202109
     DOIを用いた論文検索結果へのリンク
199. Prediction of the tumor response and survival based on computed tomography in esophageal squamous cell carcinoma after trimodality therapy, SURGERY TODAY, 51巻, 9号, pp. 1496-1505, 202109
     DOIを用いた論文検索結果へのリンク
200. Salvage Surgery for Non-Small Cell Lung Cancer After Definitive Radiotherapy, ANNALS OF THORACIC SURGERY, 112巻, 3号, pp. 862-873, 202109
     DOIを用いた論文検索結果へのリンク
201. Segmentectomy vs Lobectomy for Clinical Stage IA Lung Adenocarcinoma With Spread Through Air Spaces, ANNALS OF THORACIC SURGERY, 112巻, 3号, pp. 935-943, 202109
     DOIを用いた論文検索結果へのリンク
202. Certified thoracic surgeons in Japan: a national database survey on risk-adjusted mortality associated with lung resection, SURGERY TODAY, 51巻, 8号, pp. 1268-1275, 202108
     DOIを用いた論文検索結果へのリンク
203. The impact of pathological lymph node metastasis with lymphatic invasion on the survival of patients with clinically node-negative non-small cell lung cancer: A multicenter study, LUNG CANCER, 158巻, pp. 9-14, 202108
     DOIを用いた論文検索結果へのリンク
204. Febrile neutropenia and role of prophylactic granulocyte colony-stimulating factor in docetaxel and cyclophosphamide chemotherapy for breast cancer, SUPPORTIVE CARE IN CANCER, 29巻, 7号, pp. 3507-3512, 202107
     DOIを用いた論文検索結果へのリンク
205. Breast cancer detection by dedicated breast positron emission tomography according to the World Health Organization classification of breast tumors, EJSO, 47巻, 7号, pp. 1588-1592, 202107
     DOIを用いた論文検索結果へのリンク
206. Prognostic role of interstitial pneumonia with or without emphysema in patients with clinical stage I lung cancer, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 51巻, 7号, pp. 1123-1131, 202107
     DOIを用いた論文検索結果へのリンク
207. Prediction of Acute Exacerbation of Interstitial Pneumonia Using Visual Evaluation of PET, ANNALS OF THORACIC SURGERY, 112巻, 1号, pp. 264-270, 202107
     DOIを用いた論文検索結果へのリンク
208. Anatomical location and number of metastatic lymph nodes for prognosis of non-small cell lung cancer, JOURNAL OF THORACIC DISEASE, 13巻, 7号, pp. 4083-+, 202107
     DOIを用いた論文検索結果へのリンク
209. Phase 2 Study of YS110, a Recombinant Humanized Anti-CD26 Monoclonal Antibody, in Japanese Patients With Advanced Malignant Pleural Mesothelioma, JTO CLINICAL AND RESEARCH REPORTS, 2巻, 6号, 202106
     DOIを用いた論文検索結果へのリンク
210. Comparison of Open and Thoracoscopic Esophagectomy in Patients With Locally Advanced Esophageal Squamous Cell Carcinoma After Neoadjuvant Therapy, ANTICANCER RESEARCH, 41巻, 6号, pp. 3011-3021, 202106
     DOIを用いた論文検索結果へのリンク
211. Performance of dedicated breast positron emission tomography in the detection of small and low-grade breast cancer, BREAST CANCER RESEARCH AND TREATMENT, 187巻, 1号, pp. 125-133, 202105
     DOIを用いた論文検索結果へのリンク
212. Long-Term Outcomes After Sublobar Resection Versus Lobectomy in Patients With Clinical Stage IA Lung Adenocarcinoma Meeting the Node-Negative Criteria Defined by High-Resolution Computed Tomography and [F-18]-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography, CLINICAL LUNG CANCER, 22巻, 3号, pp. E431-E437, 202105
     DOIを用いた論文検索結果へのリンク
213. Patient Selection of Sublobar Resection Using Visual Evaluation of Positron-Emission Tomography (PET) for Early-Stage Lung Adenocarcinoma, ANNALS OF SURGICAL ONCOLOGY, 28巻, 4号, pp. 2068-2075, 202104
     DOIを用いた論文検索結果へのリンク
214. Impact of postoperative pleurodesis on pulmonary function after lung segmentectomy, JTCVS OPEN, 5巻, pp. 110-118, 202103
     DOIを用いた論文検索結果へのリンク
215. Clinical Efficacy and Safety of Nivolumab in Japanese Patients With Malignant Pleural Mesothelioma: 3-Year Results of the MERIT Study, JTO CLINICAL AND RESEARCH REPORTS, 2巻, 3号, 202103
     DOIを用いた論文検索結果へのリンク
216. Distribution of Lymph Node Metastasis in Esophageal Squamous Cell Carcinoma After Trimodal Therapy, ANNALS OF SURGICAL ONCOLOGY, 28巻, 3号, pp. 1798-1807, 202103
     DOIを用いた論文検索結果へのリンク
217. Salvage surgery for non-small cell lung cancer after tyrosine kinase inhibitor treatment, LUNG CANCER, 153巻, pp. 108-116, 202103
     DOIを用いた論文検索結果へのリンク
218. Novel technique for identification of the pulmonary intersegmental plane using manual jet ventilation during pulmonary segmentectomy, VIDEOSURGERY AND OTHER MINIINVASIVE TECHNIQUES, 16巻, 1号, pp. 169-174, 202103
     DOIを用いた論文検索結果へのリンク
219. Oncologic Outcomes of Complex Segmentectomy: A Multicenter Propensity Score-Matched Analysis, ANNALS OF THORACIC SURGERY, 111巻, 3号, pp. 1044-1051, 202103
     DOIを用いた論文検索結果へのリンク
220. Prediction of Unexpected N2 Disease Associated With Clinical T1-2N0-1M0 Non-Small-Cell Lung Cancer, CLINICAL LUNG CANCER, 22巻, 2号, pp. 120-+, 202103
     DOIを用いた論文検索結果へのリンク
221. Surgical Procedure Selection for Stage I Lung Cancer: Complex Segmentectomy versus Wedge Resection, CLINICAL LUNG CANCER, 22巻, 2号, pp. E224-E233, 202103
     DOIを用いた論文検索結果へのリンク
222. Surgical challenges in multimodal treatment of N2-stage IIIA non-small cell lung cancer, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 51巻, 3号, pp. 333-344, 202103
     DOIを用いた論文検索結果へのリンク
223. Appropriate Extent of Lymphadenectomy in Segmentectomy: A Multicenter Study, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 51巻, 3号, pp. 451-458, 202103
     DOIを用いた論文検索結果へのリンク
224. Utility of Newly Proposed Grading System From International Association for the Study of Lung Cancer for Invasive Lung Adenocarcinoma, JTO CLINICAL AND RESEARCH REPORTS, 2巻, 2号, 202102
     DOIを用いた論文検索結果へのリンク
225. Glypican-1 is a novel immunohistochemical marker to differentiate poorly differentiated squamous cell carcinoma from solid predominant adenocarcinoma of the lung, TRANSLATIONAL LUNG CANCER RESEARCH, 10巻, 2号, pp. 766-+, 202102
     DOIを用いた論文検索結果へのリンク
226. Thoracic and cardiovascular surgeries in Japan during 2018 Annual report by the Japanese Association for Thoracic Surgery, GENERAL THORACIC AND CARDIOVASCULAR SURGERY, 69巻, 1号, pp. 179-212, 202101
     DOIを用いた論文検索結果へのリンク
227. Nivolumab versus chemotherapy in Japanese patients with advanced esophageal squamous cell carcinoma: a subgroup analysis of a multicenter, randomized, open-label, phase 3 trial (ATTRACTION-3), ESOPHAGUS, 18巻, 1号, pp. 90-99, 202101
     DOIを用いた論文検索結果へのリンク
228. A phase II study of cisplatin plus vinorelbine combined with atezolizumab as adjuvant therapy for completely resected non-small-cell lung cancer with EGFR mutation (West Japan Oncology Group 11719L/ADJUST study), THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 13巻, 202101
     DOIを用いた論文検索結果へのリンク
229. Long-term results of definitive chemoradiotherapy for unresectable locally advanced esophageal squamous cell carcinoma, JOURNAL OF RADIATION RESEARCH, 62巻, 1号, pp. 142-148, 202101
     DOIを用いた論文検索結果へのリンク
230. Recent advances and future perspectives in adjuvant and neoadjuvant immunotherapies for lung cancer, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 51巻, 1号, pp. 28-36, 202101
     DOIを用いた論文検索結果へのリンク
231. Preoperative nivolumab to evaluate pathological response in patients with stage I non-small cell lung cancer: a study protocol of phase II trial (POTENTIAL), BMJ OPEN, 11巻, 3号, 2021
     DOIを用いた論文検索結果へのリンク
232. Complete Response for Advanced Hepatocellular Carcinoma by Conversion Surgery Therapy Following a Good Response of Regorafenib Despite Rapid Progressive Disease with Sorafenib, INTERNAL MEDICINE, 60巻, 13号, pp. 2047-2053, 2021
     DOIを用いた論文検索結果へのリンク
233. Randomized Phase III Study of Irinotecan Plus Cisplatin Versus Etoposide Plus Cisplatin for Completely Resected High-Grade Neuroendocrine Carcinoma of the Lung: JCOG1205/1206, JOURNAL OF CLINICAL ONCOLOGY, 38巻, 36号, pp. 4292-+, 20201220
     DOIを用いた論文検索結果へのリンク
234. Abemaciclib Combined With Endocrine Therapy for the Adjuvant Treatment of HR+, HER2-, Node-Positive, High-Risk, Early Breast Cancer (monarchE), JOURNAL OF CLINICAL ONCOLOGY, 38巻, 34号, 20201201
     DOIを用いた論文検索結果へのリンク
235. Microwave Breast Imaging Using Rotational Bistatic Impulse Radar for the Detection of Breast Cancer: Protocol for a Prospective Diagnostic Study, JOURNAL OF MEDICAL INTERNET RESEARCH, 22巻, 10号, 20201019
     DOIを用いた論文検索結果へのリンク
236. Circulating microRNA/isomiRs as novel biomarkers of esophageal squamous cell carcinoma, PLOS ONE, 15巻, 4号, 20200406
     DOIを用いた論文検索結果へのリンク
237. A phase III study of adjuvant chemotherapy in patients with completely resected, node-negative non-small cell lung cancer (JCOG 0707), JTCVS OPEN, 4巻, pp. 90-102, 202012
     DOIを用いた論文検索結果へのリンク
238. A Two-Stage Rotational Surface Clutter Suppression Method for Microwave Breast Imaging With Multistatic Impulse-Radar Detector, IEEE TRANSACTIONS ON INSTRUMENTATION AND MEASUREMENT, 69巻, 12号, pp. 9586-9598, 202012
     DOIを用いた論文検索結果へのリンク
239. Prognosis of segmentectomy and lobectomy for radiologically aggressive small-sized lung cancer, EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 58巻, 6号, pp. 1245-1253, 202012
     DOIを用いた論文検索結果へのリンク
240. Src-Homology 2 Domain-Containing Phosphatase 2 in Resected EGFR Mutation-Positive Lung Adenocarcinoma, JTO CLINICAL AND RESEARCH REPORTS, 1巻, 4号, 202011
     DOIを用いた論文検索結果へのリンク
241. Comparing Segmentectomy and Lobectomy for Clinical Stage IA Solid-dominant Lung Cancer Measuring 2.1 to 3 cm, CLINICAL LUNG CANCER, 21巻, 6号, pp. E528-E538, 202011
     DOIを用いた論文検索結果へのリンク
242. Clinical features and prognosis of clinical N0 non-small cell lung cancer exceeding 30 mm, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 50巻, 11号, pp. 1306-1312, 202011
     DOIを用いた論文検索結果へのリンク
243. Predictions of Pathological Features and Recurrence Based on FDG-PET Findings of Esophageal Squamous Cell Carcinoma after Trimodal Therapy, ANNALS OF SURGICAL ONCOLOGY, 27巻, 11号, pp. 4422-4430, 202010
     DOIを用いた論文検索結果へのリンク
244. Microwave Breast Imaging Using Rotational Bistatic Impulse Radar for the Detection of Breast Cancer: Protocol for a Prospective Diagnostic Study, JMIR RESEARCH PROTOCOLS, 9巻, 10号, 202010
     DOIを用いた論文検索結果へのリンク
245. Prediction of Lymph Node Metastasis Using Semiquantitative Evaluation of PET for Lung Adenocarcinoma, ANNALS OF THORACIC SURGERY, 110巻, 3号, pp. 1036-1042, 202009
     DOIを用いた論文検索結果へのリンク
246. SOX6 is a Novel Immunohistochemical Marker for Differential Diagnosis of Epithelioid Mesothelioma From Lung Adenocarcinoma, AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 44巻, 9号, pp. 1259-1265, 202009
     DOIを用いた論文検索結果へのリンク
247. Wedge resection as an alternative treatment for octogenarian and older patients with early-stage non-small-cell lung cancer, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 50巻, 9号, pp. 1051-1057, 202009
     DOIを用いた論文検索結果へのリンク
248. Sublobar resection versus lobectomy for patients with resectable stage I non-small cell lung cancer with idiopathic pulmonary fibrosis: a phase III study evaluating survival (JCOG1708, SURPRISE), JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 50巻, 9号, pp. 1076-1079, 202009
     DOIを用いた論文検索結果へのリンク
249. Prevention of Postoperative Prolonged Air Leak After Pulmonary Resection, THORACIC SURGERY CLINICS, 30巻, 3号, pp. 305-+, 202008
     DOIを用いた論文検索結果へのリンク
250. Risk Factors for Recurrence in Esophageal Squamous Cell Carcinoma Without Pathological Complete Response After Trimodal Therapy, ANTICANCER RESEARCH, 40巻, 8号, pp. 4387-4394, 202008
     DOIを用いた論文検索結果へのリンク
251. LPrognostic Impact of Programmed Death-ligand 1 and Surrounding Immune Status on Stage I Lung Cancer, CLINICAL LUNG CANCER, 21巻, 4号, pp. E302-E314, 202007
     DOIを用いた論文検索結果へのリンク
252. Are segmentectomy and lobectomy comparable in terms of curative intent for early stage non-small cell lung cancer?, GENERAL THORACIC AND CARDIOVASCULAR SURGERY, 68巻, 7号, pp. 703-706, 202007
     DOIを用いた論文検索結果へのリンク
253. Evaluation of plasma EGFR mutation as an early predictor of response of erlotinib plus bevacizumab treatment in the NEJ026 study, EBIOMEDICINE, 57巻, 202007
     DOIを用いた論文検索結果へのリンク
254. Investigation of surgical technique for bronchial stump closure after lobectomy in animal model, GENERAL THORACIC AND CARDIOVASCULAR SURGERY, 68巻, 6号, pp. 609-614, 202006
     DOIを用いた論文検索結果へのリンク
255. Tumor-infiltrating Lymphocyte Score Based on FDG PET/CT for Predicting the Effect of Neoadjuvant Chemotherapy in Breast Cancer, ANTICANCER RESEARCH, 40巻, 6号, pp. 3395-3400, 202006
     DOIを用いた論文検索結果へのリンク
256. Classification of Abnormal Findings on Ring-type Dedicated Breast PET for the Detection of Breast Cancer, ANTICANCER RESEARCH, 40巻, 6号, pp. 3491-3497, 202006
     DOIを用いた論文検索結果へのリンク
257. Predicting the presence of breast cancer using circulating small RNAs, including those in the extracellular vesicles, CANCER SCIENCE, 111巻, 6号, pp. 2104-2115, 202006
     DOIを用いた論文検索結果へのリンク
258. Biological Effects of Low-Dose Chest CT on Chromosomal DNA, RADIOLOGY, 295巻, 2号, pp. 439-445, 202005
     DOIを用いた論文検索結果へのリンク
259. Solid Tumor Size of 2 cm Divides Outcomes of Patients With Mixed Ground Glass Opacity Lung Tumors, ANNALS OF THORACIC SURGERY, 109巻, 5号, pp. 1530-1536, 202005
     DOIを用いた論文検索結果へのリンク
260. Diagnostic performance of peripheral leukocyte telomere G-tail length for detecting breast cancer, CANCER SCIENCE, 111巻, 5号, pp. 1856-1861, 202005
     DOIを用いた論文検索結果へのリンク
261. Prospective, randomized, cross-over pilot study of the effects of Rikkunshito, a Japanese traditional herbal medicine, on anorexia and plasma-acylated ghrelin levels in lung cancer patients undergoing cisplatin-based chemotherapy, INVESTIGATIONAL NEW DRUGS, 38巻, 2号, pp. 485-492, 202004
     DOIを用いた論文検索結果へのリンク
262. Predicting Severe Postoperative Complication in Patients With Lung Cancer and Interstitial Pneumonia, ANNALS OF THORACIC SURGERY, 109巻, 4号, pp. 1054-1060, 202004
     DOIを用いた論文検索結果へのリンク
263. Thoracic and cardiovascular surgeries in Japan during 2017 Annual report by the Japanese Association for Thoracic Surgery, GENERAL THORACIC AND CARDIOVASCULAR SURGERY, 68巻, 4号, pp. 414-449, 202004
     DOIを用いた論文検索結果へのリンク
264. Initial experience of robotic anatomical segmentectomy for non-small cell lung cancer, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 50巻, 4号, pp. 440-445, 202004
     DOIを用いた論文検索結果へのリンク
265. Intense Expression of EGFR L858R Characterizes the Micropapillary Component and L858R Is Associated with the Risk of Recurrence in pN0M0 Lung Adenocarcinoma with the Micropapillary Component, ANNALS OF SURGICAL ONCOLOGY, 27巻, 3号, pp. 945-955, 202003
     DOIを用いた論文検索結果へのリンク
266. Positive EGFR mutation status is a risk of recurrence in pN0-1 lung adenocarcinoma when combined with pathological stage and histological subtype: A retrospective multi-center analysis, LUNG CANCER, 141巻, pp. 107-113, 202003
     DOIを用いた論文検索結果へのリンク
267. Tumor Response in Esophageal Squamous Cell Carcinoma Treated With Neoadjuvant Chemotherapy Followed by Surgery, ANTICANCER RESEARCH, 40巻, 2号, pp. 1153-1160, 202002
     DOIを用いた論文検索結果へのリンク
268. Complex segmentectomy in the treatment of stage IA non-small-cell lung cancer, EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 57巻, 1号, pp. 114-121, 202001
     DOIを用いた論文検索結果へのリンク
269. Albumin-globulin ratio is a predictive biomarker of antitumor effect of anti-PD-1 antibody in patients with non-small cell lung cancer, INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 25巻, 1号, pp. 74-81, 202001
     DOIを用いた論文検索結果へのリンク
270. Albumin-globulin ratio is a predictive biomarker of antitumor effect of anti-PD-1 antibody in patients with non-small cell lung cancer, INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 25巻, 1号, pp. 74-81, 202001
     DOIを用いた論文検索結果へのリンク
271. Thoracoscopic double-flap reconstruction for esophagogastric junction cancer: A case report, INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 67巻, pp. 102-105, 2020
     DOIを用いた論文検索結果へのリンク
272. Successful Management of Esophageal Cancer With Perforation Using Bypass Surgery Followed by Definitive Chemoradiotherapy, IN VIVO, 34巻, 4号, pp. 2169-2172, 2020
     DOIを用いた論文検索結果へのリンク
273. Targeting PKC iota-PAK1 signaling pathways in EGFR and KRAS mutant adenocarcinoma and lung squamous cell carcinoma, CELL COMMUNICATION AND SIGNALING, 17巻, 1号, 20191028
     DOIを用いた論文検索結果へのリンク
274. Guanylate binding protein 1 (GBP-1) promotes cell motility and invasiveness of lung adenocarcinoma, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 518巻, 2号, pp. 266-272, 20191015
     DOIを用いた論文検索結果へのリンク
275. Wedge resection versus segmentectomy in patients with stage I non-small-cell lung cancer unfit for lobectomy, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 49巻, 12号, pp. 1134-1142, 201912
     DOIを用いた論文検索結果へのリンク
276. High-Risk Factors for Recurrence of Stage I Lung Adenocarcinoma: Follow-up Data From JCOG0201, ANNALS OF THORACIC SURGERY, 108巻, 5号, pp. 1484-1490, 201911
     DOIを用いた論文検索結果へのリンク
277. Identification of Axillary Lymph Node Metastasis in Patients With Breast Cancer Using Dual-Phase FDG PET/CT, AMERICAN JOURNAL OF ROENTGENOLOGY, 213巻, 5号, pp. 1129-1135, 201911
     DOIを用いた論文検索結果へのリンク
278. Nivolumab versus chemotherapy in patients with advanced oesophageal squamous cell carcinoma refractory or intolerant to previous chemotherapy (ATTRACTION-3): a multicentre, randomised, open-label, phase 3 trial, LANCET ONCOLOGY, 20巻, 11号, pp. 1506-1517, 201911
     DOIを用いた論文検索結果へのリンク
279. The relationship between ring-type dedicated breast PET and immune microenvironment in early breast cancer, BREAST CANCER RESEARCH AND TREATMENT, 177巻, 3号, pp. 651-657, 201910
     DOIを用いた論文検索結果へのリンク
280. Novel tumor-infiltrating lymphocytes ultrasonography score based on ultrasonic tissue findings predicts tumor-infiltrating lymphocytes in breast cancer, BREAST CANCER, 26巻, 5号, pp. 573-580, 201909
     DOIを用いた論文検索結果へのリンク
281. Breast cancer cell motility is promoted by 14-3-3 gamma, BREAST CANCER, 26巻, 5号, pp. 581-593, 201909
     DOIを用いた論文検索結果へのリンク
282. Postoperative Recurrence and Survival After Segmentectomy for Clinical Stage 0 or IA Lung Cancer, CLINICAL LUNG CANCER, 20巻, 5号, pp. 397-+, 201909
     DOIを用いた論文検索結果へのリンク
283. Comparison of pulmonary segmentectomy and lobectomy: Safety results of a randomized trial, JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 158巻, 3号, pp. 895-907, 201909
     DOIを用いた論文検索結果へのリンク
284. Synchronicity of genetic variants between primary sites and metastatic lymph nodes, and prognostic impact in nodal metastatic lung adenocarcinoma, JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 145巻, 9号, pp. 2325-2333, 201909
     DOIを用いた論文検索結果へのリンク
285. Pre-existing interstitial lung abnormalities are risk factors for immune checkpoint inhibitor-induced interstitial lung disease in non-small cell lung cancer, RESPIRATORY INVESTIGATION, 57巻, 5号, pp. 451-459, 201909
     DOIを用いた論文検索結果へのリンク
286. Clinical Efficacy and Safety of Nivolumab: Results of a Multicenter, Open-label, Single-arm, Japanese Phase II study in Malignant Pleural Mesothelioma (MERIT), CLINICAL CANCER RESEARCH, 25巻, 18号, pp. 5485-5492, 201909
     DOIを用いた論文検索結果へのリンク
287. Therapeutic value of postmastectomy radiation therapy for T1-2 breast cancer with 1-3 positive lymph nodes, JOURNAL OF RADIATION ONCOLOGY, 8巻, 3号, pp. 323-328, 201909
     DOIを用いた論文検索結果へのリンク
288. Detectability of Breast Tumors in Excised Breast Tissues of Total Mastectomy by IR-UWB-Radar-Based Breast Cancer Detector, IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING, 66巻, 8号, pp. 2296-2305, 201908
     DOIを用いた論文検索結果へのリンク
289. Long-term Esophageal Cancer Survivor Treated by Bypass for Esophagobronchial Fistula After Chemoradiotherapy: A Case Report, ANTICANCER RESEARCH, 39巻, 8号, pp. 4399-4403, 201908
     DOIを用いた論文検索結果へのリンク
290. Clinical Significance of F-18-Fluorodeoxyglucose-Positron Emission Tomography-Positive Lymph Nodes to Outcomes of Trimodal Therapy for Esophageal Squamous Cell Carcinoma, ANNALS OF SURGICAL ONCOLOGY, 26巻, 6号, pp. 1869-1878, 201906
     DOIを用いた論文検索結果へのリンク
291. Traditional Japanese herbal medicine rikkunshito increases food intake and plasma acylated ghrelin levels in patients with esophageal cancer treated by cisplatin-based chemotherapy, JOURNAL OF THORACIC DISEASE, 11巻, 6号, pp. 2470-2478, 201906
     DOIを用いた論文検索結果へのリンク
292. Erlotinib plus bevacizumab versus erlotinib alone in patients with EGFR-positive advanced non-squamous non-small-cell lung cancer (NEJ026): interim analysis of an open-label, randomised, multicentre, phase 3 trial, LANCET ONCOLOGY, 20巻, 5号, pp. 625-635, 201905
     DOIを用いた論文検索結果へのリンク
293. Surgical Outcomes of Complex Versus Simple Segmentectomy for Stage I Non-Small Cell Lung Cancer, ANNALS OF THORACIC SURGERY, 107巻, 4号, pp. 1032-1039, 201904
     DOIを用いた論文検索結果へのリンク
294. Inhibition of PAI-1 limits chemotherapy resistance in lung cancer through suppressing myofibroblast characteristics of cancer-associated fibroblasts, JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 23巻, 4号, pp. 2984-2994, 201904
     DOIを用いた論文検索結果へのリンク
295. Prediction of biological characteristics of breast cancer using dual-phase FDG PET/CT, EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 46巻, 4号, pp. 831-837, 201904
     DOIを用いた論文検索結果へのリンク
296. Thoracic and cardiovascular surgery in Japan in 2016: Annual report by The Japanese Association for Thoracic Surgery, GENERAL THORACIC AND CARDIOVASCULAR SURGERY, 67巻, 4号, pp. 377-411, 201904
     DOIを用いた論文検索結果へのリンク
297. Risk assessments for broncho-pleural fistula and respiratory failure after lung cancer surgery by National Clinical Database Japan, GENERAL THORACIC AND CARDIOVASCULAR SURGERY, 67巻, 3号, pp. 297-305, 201903
     DOIを用いた論文検索結果へのリンク
298. Mucin 21 is a novel, negative immunohistochemical marker for epithelioid mesothelioma for its differentiation from lung adenocarcinoma, HISTOPATHOLOGY, 74巻, 4号, pp. 545-554, 201903
     DOIを用いた論文検索結果へのリンク
299. Early Recurrence and Cancer Death After Trimodal Therapy for Esophageal Squamous Cell Carcinoma, ANTICANCER RESEARCH, 39巻, 3号, pp. 1433-1440, 201903
     DOIを用いた論文検索結果へのリンク
300. Prolonged post-recurrence survival following pleurectomy/decortication for malignant pleural mesothelioma, ONCOLOGY LETTERS, 17巻, 3号, pp. 3607-3614, 201903
     DOIを用いた論文検索結果へのリンク
301. Lung cancer risk stratification using methylation profile in the oral epithelium, Asian Cardiovasc Thorac Ann, 27巻, 2号, pp. 87-92, 201902
302. Metachronous Lung Cancer After Pleurectomy/Decortication, ANNALS OF THORACIC SURGERY, 107巻, 1号, pp. E1-E3, 201901
     DOIを用いた論文検索結果へのリンク
303. Prospective feasibility study of sealing pulmonary vessels with energy in lung surgery, JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 157巻, 1号, pp. 388-395, 201901
     DOIを用いた論文検索結果へのリンク
304. Three-step surgical treatment of aortoesophageal fistula after thoracic endovascular aortic repair: A case report, INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 65巻, pp. 221-224, 2019
     DOIを用いた論文検索結果へのリンク
305. Multicenter phase II study on cisplatin, pemetrexed, and bevacizumab followed by maintenance with pemetrexed and bevacizumab for patients with advanced or recurrent nonsquamous non-small cell lung cancer: MAP study, BMC CANCER, 18巻, 20181210
     DOIを用いた論文検索結果へのリンク
306. Aminopeptidase N/CD13 as a potential therapeutic target in malignant pleural mesothelioma, EUROPEAN RESPIRATORY JOURNAL, 51巻, 5号, 20180501
     DOIを用いた論文検索結果へのリンク
307. MUC4 immunohistochemistry is useful in distinguishing epithelioid mesothelioma from adenocarcinoma and squamous cell carcinoma of the lung, SCIENTIFIC REPORTS, 8巻, 20180109
     DOIを用いた論文検索結果へのリンク
308. Increased risk of recurrence in resected EGFR-positive pN0M0 invasive lung adenocarcinoma, THORACIC CANCER, 9巻, 12号, pp. 1594-1602, 201812
     DOIを用いた論文検索結果へのリンク
309. Induction Chemoradiotherapy (50 Gy), Followed by Resection, for Stage IIIA-N2 Non-Small Cell Lung Cancer, ANNALS OF THORACIC SURGERY, 106巻, 4号, pp. 1018-1024, 201810
     DOIを用いた論文検索結果へのリンク
310. Thoracic and cardiovascular surgery in Japan during 2015: Annual report by The Japanese Association for Thoracic Surgery, GENERAL THORACIC AND CARDIOVASCULAR SURGERY, 66巻, 10号, pp. 581-615, 201810
     DOIを用いた論文検索結果へのリンク
311. Intratumoral heterogeneity on dedicated breast positron emission tomography predicts malignancy grade of breast cancer, BREAST CANCER RESEARCH AND TREATMENT, 171巻, 2号, pp. 315-323, 201809
     DOIを用いた論文検索結果へのリンク
312. The differences in histological changes among pulmonary vessels divided with an energy device, INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 27巻, 3号, pp. 372-378, 201809
     DOIを用いた論文検索結果へのリンク
313. Impact of Interval Between Neoadjuvant Chemoradiation and Surgery Upon Morbidity and Survival of Patients with Squamous Cell Carcinoma of Thoracic Esophagus, ANTICANCER RESEARCH, 38巻, 9号, pp. 5239-5245, 201809
     DOIを用いた論文検索結果へのリンク
314. Long-term results of neoadjuvant chemoradiotherapy using cisplatin and 5-fluorouracil followed by esophagectomy for resectable, locally advanced esophageal squamous cell carcinoma, JOURNAL OF RADIATION RESEARCH, 59巻, 5号, pp. 616-624, 201809
     DOIを用いた論文検索結果へのリンク
315. Segmentectomy Versus Lobectomy for Radiologically Pure Solid Clinical T1a-bN0M0 Lung Cancer, WORLD JOURNAL OF SURGERY, 42巻, 8号, pp. 2493-2501, 201808
     DOIを用いた論文検索結果へのリンク
316. Bronchoplasties at the Segmental Level, THORACIC SURGERY CLINICS, 28巻, 3号, pp. 299-+, 201808
     DOIを用いた論文検索結果へのリンク
317. Treatment Outcomes and Prognostic Factors After Recurrence of Esophageal Squamous Cell carcinoma, WORLD JOURNAL OF SURGERY, 42巻, 7号, pp. 2190-2198, 201807
     DOIを用いた論文検索結果へのリンク
318. Preoperative prediction of a pathologic complete response of esophageal squamous cell carcinoma to neoadjuvant chemoradiotherapy, SURGERY, 164巻, 1号, pp. 40-48, 201807
     DOIを用いた論文検索結果へのリンク
319. Evaluation of Prognostic Factors for Esophageal Squamous Cell Carcinoma Treated with Neoadjuvant Chemoradiotherapy Followed by Surgery, WORLD JOURNAL OF SURGERY, 42巻, 5号, pp. 1496-1505, 201805
     DOIを用いた論文検索結果へのリンク
320. Reassessment of Right Middle Lobe Lung Cancer: Comparison of Segments 4 and 5 Tumors, ANNALS OF THORACIC SURGERY, 105巻, 5号, pp. 1543-1550, 201805
     DOIを用いた論文検索結果へのリンク
321. Glypican-1 immunohistochemistry is a novel marker to differentiate epithelioid mesothelioma from lung adenocarcinoma, MODERN PATHOLOGY, 31巻, 5号, pp. 809-815, 201805
     DOIを用いた論文検索結果へのリンク
322. A Multicenter Randomized Controlled Study of Paclitaxel plus Carboplatin versus Oral Uracil-Tegafur as the Adjuvant Chemotherapy in Resected Non-Small Cell Lung Cancer, JOURNAL OF THORACIC ONCOLOGY, 13巻, 5号, pp. 699-706, 201805
     DOIを用いた論文検索結果へのリンク
323. A proposal for a comprehensive risk scoring system for predicting postoperative complications in octogenarian patients with medically operable lung cancer: JACS1303, EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 53巻, 4号, pp. 835-841, 201804
     DOIを用いた論文検索結果へのリンク
324. Dedicated breast PET for detecting residual disease after neoadjuvant chemotherapy in operable breast cancer: A prospective cohort study, EJSO, 44巻, 4号, pp. 444-448, 201804
     DOIを用いた論文検索結果へのリンク
325. Management pathways for solitary pulmonary nodules, JOURNAL OF THORACIC DISEASE, 10巻, pp. S860-S866, 201804
     DOIを用いた論文検索結果へのリンク
326. Portable impulse-radar detector for breast cancer: a pilot study, JOURNAL OF MEDICAL IMAGING, 5巻, 2号, 201804
     DOIを用いた論文検索結果へのリンク
327. Common Co-activation of AXL and CDCP1 in EGFR-mutation-positive Non-smallcell Lung Cancer Associated With Poor Prognosis, EBIOMEDICINE, 29巻, pp. 112-127, 201803
     DOIを用いた論文検索結果へのリンク
328. Utility of Survivin, BAP1, and Ki-67 immunohistochemistry in distinguishing epithelioid mesothelioma from reactive mesothelial hyperplasia, ONCOLOGY LETTERS, 15巻, 3号, pp. 3540-3547, 201803
     DOIを用いた論文検索結果へのリンク
329. Role of F-18-PET/CT in Predicting Prognosis of Patients With Breast Cancer After Neoadjuvant Chemotherapy, CLINICAL BREAST CANCER, 18巻, 1号, pp. 45-52, 201802
     DOIを用いた論文検索結果へのリンク
330. Postoperative complications and prognosis after lobar resection versus sublobar resection in elderly patients with clinical Stage I non-small-cell lung cancer, EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 53巻, 2号, pp. 366-371, 201802
     DOIを用いた論文検索結果へのリンク
331. A randomized Phase III trial of lobe-specific vs. systematic nodal dissection for clinical Stage I-II non-small cell lung cancer (JCOG1413), JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 48巻, 2号, pp. 190-194, 201802
     DOIを用いた論文検索結果へのリンク
332. Significance of lung biopsy for the definitive diagnosis of lung nodules in breast cancer patients, MOLECULAR AND CLINICAL ONCOLOGY, 8巻, 2号, pp. 250-256, 201802
     DOIを用いた論文検索結果へのリンク
333. Bevacizumab with Single-agent Chemotherapy in Previously Treated Non-squamous Non-small-cell Lung Cancer: Phase II Study, IN VIVO, 32巻, 5号, pp. 1155-1160, 2018
     DOIを用いた論文検索結果へのリンク
334. Which type of breast cancers is undetectable on ring-type dedicated breast PET?, CLINICAL IMAGING, 51巻, pp. 186-191, 2018
     DOIを用いた論文検索結果へのリンク
335. Therapeutic strategies and genetic profile comparisons in small cell carcinoma and large cell neuroendocrine carcinoma of the lung using next-generation sequencing, ONCOTARGET, 8巻, 65号, pp. 108936-108945, 20171212
     DOIを用いた論文検索結果へのリンク
336. Detectability of Breast Tumor by a Hand-held Impulse-Radar Detector: Performance Evaluation and Pilot Clinical Study, SCIENTIFIC REPORTS, 7巻, 20171127
     DOIを用いた論文検索結果へのリンク
337. Differences in immune response to anesthetics used for day surgery versus hospitalization surgery for breast cancer patients, CLINICAL AND TRANSLATIONAL MEDICINE, 6巻, 20170914
     DOIを用いた論文検索結果へのリンク
338. Gene expression profiling of idiopathic interstitial pneumonias (IIPs): identification of potential diagnostic markers and therapeutic targets, BMC MEDICAL GENETICS, 18巻, 20170818
     DOIを用いた論文検索結果へのリンク
339. New noncontact sensor for detecting pulmonary tumors during video-assisted thoracic surgery, JOURNAL OF SURGICAL RESEARCH, 214巻, pp. 62-68, 20170615
     DOIを用いた論文検索結果へのリンク
340. Model of lung cancer surgery risk derived from a Japanese nationwide web-based database of 78 594 patients during 2014-2015, EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 52巻, 6号, pp. 1182-1189, 201712
     DOIを用いた論文検索結果へのリンク
341. Clinicopathologic Features of Submucosal Esophageal Squamous Cell Carcinoma, ANNALS OF THORACIC SURGERY, 104巻, 6号, pp. 1858-1864, 201712
     DOIを用いた論文検索結果へのリンク
342. Clinical Prognosis of Superior Versus Basal Segment Stage I Non-Small Cell Lung Cancer, ANNALS OF THORACIC SURGERY, 104巻, 6号, pp. 1896-1901, 201712
     DOIを用いた論文検索結果へのリンク
343. Neoadjuvant and adjuvant therapy for Stage III non-small cell lung cancer, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 47巻, 12号, pp. 1112-1118, 201712
     DOIを用いた論文検索結果へのリンク
344. Effects of Neoadjuvant Chemoradiotherapy on Pathological TNM Stage and Their Prognostic Significance for Surgically-treated Esophageal Squamous Cell Carcinoma, ANTICANCER RESEARCH, 37巻, 10号, pp. 5639-5646, 201710
     DOIを用いた論文検索結果へのリンク
345. Outcomes after lobar versus sublobar resection for clinical stage I non-small cell lung cancer in patients with interstitial lung disease, JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 154巻, 3号, pp. 1089-+, 201709
     DOIを用いた論文検索結果へのリンク
346. Does the histologic predominance of pathological stage IA lung adenocarcinoma influence the extent of resection?, GENERAL THORACIC AND CARDIOVASCULAR SURGERY, 65巻, 9号, pp. 512-518, 201709
     DOIを用いた論文検索結果へのリンク
347. Identification of DAB2 and Intelectin-1 as Novel Positive Immunohistochemical Markers of Epithelioid Mesothelioma by Transcriptome Microarray Analysis for Its Differentiation From Pulmonary Adenocarcinoma, AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 41巻, 8号, pp. 1045-1052, 201708
     DOIを用いた論文検索結果へのリンク
348. Clinical benefit of neoadjuvant chemoradiotherapy for the avoidance of pneumonectomy; assessment in 12 consecutive centrally located non-small cell lung cancers, GENERAL THORACIC AND CARDIOVASCULAR SURGERY, 65巻, 7号, pp. 392-399, 201707
     DOIを用いた論文検索結果へのリンク
349. Role of Postoperative C-Reactive Protein Levels in Predicting Prognosis After Surgical Treatment of Esophageal Cancer, WORLD JOURNAL OF SURGERY, 41巻, 6号, pp. 1558-1565, 201706
     DOIを用いた論文検索結果へのリンク
350. MUC4, a novel immunohistochemical marker identified by gene expression profiling, differentiates pleural sarcomatoid mesothelioma from lung sarcomatoid carcinoma, MODERN PATHOLOGY, 30巻, 5号, pp. 672-681, 201705
     DOIを用いた論文検索結果へのリンク
351. Utility and pitfalls of immunohistochemistry in the differential diagnosis between epithelioid mesothelioma and poorly differentiated lung squamous cell carcinoma, HISTOPATHOLOGY, 70巻, 3号, pp. 375-384, 201702
     DOIを用いた論文検索結果へのリンク
352. Is cancer history really an exclusion criterion for clinical trial of lung cancer ? Influence of gastrointestinal tract cancer history on the outcomes of lung cancer surgery, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 47巻, 2号, pp. 145-156, 201702
     DOIを用いた論文検索結果へのリンク
353. Preoperative predictors of distant recurrence in patients with clinical stage IA lung adenocarcinoma undergoing complete resection, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 47巻, 2号, pp. 157-163, 201702
     DOIを用いた論文検索結果へのリンク
354. Second predominant subtype predicts outcomes of intermediate-malignant invasive lung adenocarcinoma, EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 51巻, 2号, pp. 218-222, 201702
     DOIを用いた論文検索結果へのリンク
355. Limited resection for early-stage non-small cell lung cancer as function-preserving radical surgery: a review, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 47巻, 1号, pp. 7-11, 201701
     DOIを用いた論文検索結果へのリンク
356. CLINICAL AND MOLECULAR FEATURES OF RAPIDLY PROGRESSIVE CHRONIC HYPERSENSITIVITY PNEUMONITIS, SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES, 34巻, 1号, pp. 48-57, 2017
357. A phase II trial evaluating the efficacy and safety of perioperative pirfenidone for prevention of acute exacerbation of idiopathic pulmonary fibrosis in lung cancer patients undergoing pulmonary resection: West Japan Oncology Group 6711 L (PEOPLE Study), RESPIRATORY RESEARCH, 17巻, 20160722
     DOIを用いた論文検索結果へのリンク
358. Bevacizumab beyond disease progression after first-line treatment with bevacizumab plus chemotherapy in advanced nonsquamous non-small cell lung cancer (West Japan Oncology Group 5910L): An open-label, randomized, phase 2 trial, CANCER, 122巻, 7号, pp. 1050-1059, 20160401
     DOIを用いた論文検索結果へのリンク
359. Clinical Significance of FDG-PET to Predict Pathologic Tumor Invasion and Lymph Node Metastasis of Superficial Esophageal Squamous Cell Carcinoma, ANNALS OF SURGICAL ONCOLOGY, 23巻, 12号, pp. 4086-4092, 201611
     DOIを用いた論文検索結果へのリンク
360. Prognostic significance of vascular invasion in intermediate-grade subtype of lung adenocarcinoma, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 46巻, 11号, pp. 1015-1021, 201611
     DOIを用いた論文検索結果へのリンク
361. Prognostic Role of Subtype Classification in Small-Sized Pathologic N0 Invasive Lung Adenocarcinoma, ANNALS OF THORACIC SURGERY, 102巻, 5号, pp. 1668-1673, 201611
     DOIを用いた論文検索結果へのリンク
362. Ability of Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography to Predict Outcomes of Neoadjuvant Chemoradiotherapy Followed by Surgical Treatment for Esophageal Squamous Cell Carcinoma, ANNALS OF THORACIC SURGERY, 102巻, 4号, pp. 1132-1140, 201610
     DOIを用いた論文検索結果へのリンク
363. Long-term results after 12-year follow-up of patients treated with whole-breast and boost irradiation after breast-conserving surgery, JAPANESE JOURNAL OF RADIOLOGY, 34巻, 9号, pp. 595-604, 201609
     DOIを用いた論文検索結果へのリンク
364. Application of Lepidic Component Predominance to Adjuvant Chemotherapy with Oral Fluoropyrimidines for Stage I Lung Adenocarcinoma, CLINICAL LUNG CANCER, 17巻, 5号, pp. 433-440, 201609
     DOIを用いた論文検索結果へのリンク
365. Severity of lung fibrosis affects early surgical outcomes of lung cancer among patients with combined pulmonary fibrosis and emphysema, MEDICINE, 95巻, 29号, 201607
     DOIを用いた論文検索結果へのリンク
366. Trimodality strategy for treating malignant pleural mesothelioma: results of a feasibility study of induction pemetrexed plus cisplatin followed by extrapleural pneumonectomy and postoperative hemithoracic radiation (Japan Mesothelioma Interest Group 0601 Trial), INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 21巻, 3号, pp. 523-530, 201606
     DOIを用いた論文検索結果へのリンク
367. EVALUATION OF MALIGNANCY GRADE OF BREAST CANCER USING PERFLUBUTANE-ENHANCED ULTRASONOGRAPHY, ULTRASOUND IN MEDICINE AND BIOLOGY, 42巻, 5号, pp. 1049-1057, 201605
     DOIを用いた論文検索結果へのリンク
368. Ability of contrast-enhanced ultrasonography to determine clinical responses of breast cancer to neoadjuvant chemotherapy, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 46巻, 4号, pp. 303-309, 201604
     DOIを用いた論文検索結果へのリンク
369. Enhanced gefitinib-induced repression of the epidermal growth factor receptor pathway by ataxia telangiectasia-mutated kinase inhibition in non-small-cell lung cancer cells, CANCER SCIENCE, 107巻, 4号, pp. 444-451, 201604
     DOIを用いた論文検索結果へのリンク
370. Complete transection of the left main bronchus caused by blunt thoracic trauma in a child treated by bronchoplasty and lung parenchyma preservation, GENERAL THORACIC AND CARDIOVASCULAR SURGERY, 64巻, 2号, pp. 113-115, 201602
     DOIを用いた論文検索結果へのリンク
371. Negative prognostic influence of micropapillary pattern in stage IA lung adenocarcinoma, EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 49巻, 1号, pp. 293-299, 201601
     DOIを用いた論文検索結果へのリンク
372. Use of Anti-Noxa Antibody for Differential Diagnosis between Epithelioid Mesothelioma and Reactive Mesothelial Hyperplasia, PATHOBIOLOGY, 83巻, 1号, pp. 33-40, 2016
     DOIを用いた論文検索結果へのリンク
373. Role of definitive chemoradiotherapy using docetaxel and 5-fluorouracil in patients with unresectable locally advanced esophageal squamous cell carcinoma: a phase II study, DISEASES OF THE ESOPHAGUS, 29巻, 8号, pp. 1115-1120, 2016
     DOIを用いた論文検索結果へのリンク
374. Feasibility and efficacy of salvage lung resection after definitive chemoradiation therapy for Stage III non-small-cell lung cancer., Interactive cardiovascular and thoracic surgery, 23巻, 6号, pp. 895-901, 2016
375. Surgical Resection of Thoracic Esophageal Cancer with Interstitial Lung Disease: A Case Report., Hiroshima journal of medical sciences, 65巻, 1号, pp. 19-23, 2016
376. Completion lobectomy after radical segmentectomy for pulmonary malignancies., Asian cardiovascular & thoracic annals, 24巻, 5号, pp. 450-454, 2016
377. Randomized Phase II Study of Adjuvant Chemotherapy with Long-term S-1 versus Cisplatin+S-1 in Completely Resected Stage II-IIIA Non-Small Cell Lung Cancer, CLINICAL CANCER RESEARCH, 21巻, 23号, pp. 5245-5252, 20151201
     DOIを用いた論文検索結果へのリンク
378. Impact of Lepidic Component Occupancy on Effects of Adjuvant Chemotherapy for Lung Adenocarcinoma., Annals of thoracic surgery, 20150820
379. The intracellular domain of cell adhesion molecule 1 is present in emphysematous lungs and induces lung epithelial cell apoptosis, JOURNAL OF BIOMEDICAL SCIENCE, 22巻, 20150811
     DOIを用いた論文検索結果へのリンク
380. Randomized phase II study of adjuvant chemotherapy with long-term S-1 versus cisplatin+S-1 in comletely resected stage II-IIIA non-small cell lung cancer., Clinical cancer research, 20150807
381. Increased ectodomain shedding of cell adhesion molecule 1 as a cause of type II alveolar epithelial cell apoptosis in patients with idiopathic interstitial pneumonia, RESPIRATORY RESEARCH, 16巻, 20150801
     DOIを用いた論文検索結果へのリンク
382. Surgical Outcomes of Lung Cancer in Patients with Combined Pulmonary Fibrosis and Emphysema., Annals of surgical oncology, 20150509
383. Negative prognostic influence of micropapillary pattern in stage IA lung adenocarcinoma., European journal of cardio-thoracic surgery, 20150311
384. Impact of Lepidic Component Occupancy on Effects of Adjuvant Chemotherapy for Lung Adenocarcinoma, ANNALS OF THORACIC SURGERY, 100巻, 6号, pp. 2079-2086, 201512
     DOIを用いた論文検索結果へのリンク
385. Surgical Outcomes of Lung Cancer in Patients with Combined Pulmonary Fibrosis and Emphysema, ANNALS OF SURGICAL ONCOLOGY, 22巻, pp. S1371-S1379, 201512
     DOIを用いた論文検索結果へのリンク
386. Association between [F-18]-fluoro-2-deoxyglucose uptake and expressions of hypoxia-induced factor 1 alpha and glucose transporter 1 in non-small cell lung cancer, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 45巻, 12号, pp. 1154-1161, 201512
     DOIを用いた論文検索結果へのリンク
387. Prognostic value of the new IASLC/ATS/ERS classification of clinical stage IA lung adenocarcinoma., Lung Cancer, 90巻, 2号, pp. 199-204, 201511
388. Prognostic value of the new IASLC/ATS/ERS classification of clinical stage IA lung adenocarcinoma, LUNG CANCER, 90巻, 2号, pp. 199-204, 201511
     DOIを用いた論文検索結果へのリンク
389. Prognostic signature of protocadherin 10 methylation in curatively resected pathological stage I non-small-cell lung cancer, CANCER MEDICINE, 4巻, 10号, pp. 1536-1546, 201510
     DOIを用いた論文検索結果へのリンク
390. Radiologic findings to predict low-grade malignant tumour among clinical T1bN0 lung adenocarcinomas: lessons from histological subtypes, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 45巻, 8号, pp. 767-773, 201508
     DOIを用いた論文検索結果へのリンク
391. Prediction of lymph node status in clinical stage IA squamous cell carcinoma of the lung, EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 47巻, 6号, pp. 1022-1026, 201506
     DOIを用いた論文検索結果へのリンク
392. Results of Neoadjuvant Chemoradiotherapy With Docetaxel and 5-Fluorouracil Followed by Esophagectomy to Treat Locally Advanced Esophageal Cancer, ANNALS OF THORACIC SURGERY, 99巻, 6号, pp. 1887-1893, 201506
     DOIを用いた論文検索結果へのリンク
393. Methylated DLX4 Predicts Response to Pathologic Stage I Non-Small Cell Lung Cancer Resection, ANNALS OF THORACIC SURGERY, 99巻, 5号, pp. 1746-1754, 201505
     DOIを用いた論文検索結果へのリンク
394. The Efficacy and Safety of Preoperative Chemotherapy With Triweekly Abraxane and Cyclophosphamide Followed by 5-Fluorouracil, Epirubicin, and Cyclophosphamide Therapy for Resectable Breast Cancer: A Multicenter Clinical Trial, CLINICAL BREAST CANCER, 15巻, 2号, pp. 110-116, 201504
     DOIを用いた論文検索結果へのリンク
395. Histologic changes associated with the use of fibrinogen- and thrombin-impregnated collagen in the prevention of pulmonary air leakage, JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 149巻, 4号, pp. 982-988, 201504
     DOIを用いた論文検索結果へのリンク
396. What are the radiologic findings predictive of indolent lung adenocarcinoma?, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 45巻, 4号, pp. 367-372, 201504
     DOIを用いた論文検索結果へのリンク
397. Surgical outcomes of non-small-cell lung carcinoma in patients previously treated for gastric cancer, EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 47巻, 4号, pp. 648-652, 201504
     DOIを用いた論文検索結果へのリンク
398. Emergency escape surgery for a gastro-bronchial fistula with respiratory failure that developed after esophagectomy, Surgery Today, 45巻, 3号, pp. 369-373, 201503
     DOIを用いた論文検索結果へのリンク
399. Comparison of Malignant Grade Between Pure and Partially Invasive Types of Early Lung Adenocarcinoma, ANNALS OF THORACIC SURGERY, 99巻, 3号, pp. 956-960, 201503
     DOIを用いた論文検索結果へのリンク
400. Prognostic impact of lymphatic invasion for pathological stage I squamous cell carcinoma of the lung, GENERAL THORACIC AND CARDIOVASCULAR SURGERY, 63巻, 3号, pp. 153-158, 201503
     DOIを用いた論文検索結果へのリンク
401. Utility of F-18 FDG-PET/CT for predicting prognosis of luminal-type breast cancer, BREAST CANCER RESEARCH AND TREATMENT, 150巻, 1号, pp. 209-217, 201502
     DOIを用いた論文検索結果へのリンク
402. The Rho GTPase Rnd1 suppresses mammary tumorigenesis and EMT by restraining Ras-MAPK signalling, NATURE CELL BIOLOGY, 17巻, 1号, pp. 81-+, 201501
     DOIを用いた論文検索結果へのリンク
403. Effects of neoadjuvant chemoradiotherapy on postoperative morbidity and mortality associated with esophageal cancer, DISEASES OF THE ESOPHAGUS, 28巻, 4号, pp. 358-364, 2015
     DOIを用いた論文検索結果へのリンク
404. The Difference in Maximum Standardized Uptake Value among Lung Adenocarcinomas Located at the Upper and Lower Zone on PET/CT, RESPIRATION, 90巻, 4号, pp. 293-298, 2015
     DOIを用いた論文検索結果へのリンク
405. Complex permittivities of breast tumor tissues obtained from cancer surgeries, APPLIED PHYSICS LETTERS, 104巻, 25号, 20140623
     DOIを用いた論文検索結果へのリンク
406. Prognosis of Lung Cancer Patients with a Past History of Colorectal Cancer, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 44巻, 11号, pp. 1088-1095, 201411
     DOIを用いた論文検索結果へのリンク
407. Role of FDG-PET/CT in Prediction of Underestimation of Invasive Breast Cancer in Cases of Ductal Carcinoma In Situ Diagnosed at Needle Biopsy, CLINICAL BREAST CANCER, 14巻, 5号, pp. 358-364, 201410
     DOIを用いた論文検索結果へのリンク
408. Propensity score-matched analysis of adjuvant chemotherapy for stage I non-small cell lung cancer, JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 148巻, 4号, pp. 1179-1185, 201410
     DOIを用いた論文検索結果へのリンク
409. Segmentectomy for clinical stage IA lung adenocarcinoma showing solid dominance on radiology, EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 46巻, 4号, pp. 637-642, 201410
     DOIを用いた論文検索結果へのリンク
410. Three models for predicting the risk of non-sentinel lymph node metastasis in Japanese breast cancer patients, BREAST CANCER, 21巻, 5号, pp. 571-575, 201409
     DOIを用いた論文検索結果へのリンク
411. Hemoglobin Level Influences Tumor Response and Survival After Neoadjuvant Chemoradiotherapy for Esophageal Squamous Cell Carcinoma, WORLD JOURNAL OF SURGERY, 38巻, 8号, pp. 2046-2051, 201408
     DOIを用いた論文検索結果へのリンク
412. Prediction for prognosis of resected pT1a-lbN0M0 adenocarcinoma based on tumor size and histological status: Relationship of TNM and IASLC/ATS/ERS classifications, LUNG CANCER, 85巻, 2号, pp. 270-275, 201408
     DOIを用いた論文検索結果へのリンク
413. Role of Positron Emission Tomography/Computed Tomography Findings for Adjuvant Chemotherapy Indications in Stage T1b-2aN0M0 Lung Adenocarcinoma, ANNALS OF THORACIC SURGERY, 98巻, 2号, pp. 417-423, 201408
     DOIを用いた論文検索結果へのリンク
414. Role of lymphatic invasion in the prognosis of patients with clinical node-negative and pathologic node-positive lung adenocarcinoma, JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 147巻, 6号, pp. 1820-1826, 201406
     DOIを用いた論文検索結果へのリンク
415. Sublobar Resection for Lung Adenocarcinoma Meeting Node-Negative Criteria on Preoperative Imaging, ANNALS OF THORACIC SURGERY, 97巻, 5号, pp. 1701-1707, 201405
     DOIを用いた論文検索結果へのリンク
416. Increased ectodomain shedding of lung epithelial cell adhesion molecule 1 as a cause of increased alveolar cell apoptosis in emphysema, THORAX, 69巻, 3号, pp. 223-231, 201403
     DOIを用いた論文検索結果へのリンク
417. Segmentectomy versus lobectomy for clinical stage IA lung adenocarcinoma., Annals of cardiothoracic surgery, 3巻, 2号, pp. 153-159, 201403
418. alpha-Parvin, a pseudopodial constituent, promotes cell motility and is associated with lymph node metastasis of lobular breast carcinoma, BREAST CANCER RESEARCH AND TREATMENT, 144巻, 1号, pp. 59-69, 201402
     DOIを用いた論文検索結果へのリンク
419. Esophageal Bypass Operation Prior to Definitive Chemoradiotherapy in Advanced Esophageal Cancer With Tracheobronchial Invasion, ANNALS OF THORACIC SURGERY, 97巻, 1号, pp. 290-295, 201401
     DOIを用いた論文検索結果へのリンク
420. Appropriate Sublobar Resection Choice for Ground Glass Opacity-Dominant Clinical Stage IA Lung Adenocarcinoma Wedge Resection or Segmentectomy, CHEST, 145巻, 1号, pp. 66-71, 201401
     DOIを用いた論文検索結果へのリンク
421. Lung Abscess Presenting as Tension Pyopneumothorax in a Gastrointestinal Cancer Patient, ANNALS OF THORACIC AND CARDIOVASCULAR SURGERY, 20巻, pp. 478-481, 2014
     DOIを用いた論文検索結果へのリンク
422. 自治体のサポートによる乳がん検診のための人材育成, 日乳癌検診学会誌, 22巻, 1号, pp. 45-50, 20130301
423. Methylation of breast cancer susceptibility gene 1 (BRCA1) predicts recurrence in patients with curatively resected stage I nonsmall cell lung cancer, CANCER, 119巻, 4号, pp. 792-798, 20130215
     DOIを用いた論文検索結果へのリンク
424. Involvement of homologous recombination in the synergism between cisplatin and poly (ADP-ribose) polymerase inhibition, CANCER SCIENCE, 104巻, 12号, pp. 1593-1599, 201312
     DOIを用いた論文検索結果へのリンク
425. Prognostic Role of Positron Emission Tomography and High-Resolution Computed Tomography in Clinical Stage IA Lung Adenocarcinoma, ANNALS OF THORACIC SURGERY, 96巻, 6号, pp. 1958-1965, 201312
     DOIを用いた論文検索結果へのリンク
426. Classifications of N2 None-Small-Cell Lung Cancer Based on the Number and Rate of Metastatic Mediastinal Lymph Nodes, CLINICAL LUNG CANCER, 14巻, 6号, pp. 651-657, 201311
     DOIを用いた論文検索結果へのリンク
427. Role of FDG-PET/CT in evaluating surgical outcomes of operable breast cancer - Usefulness for malignant grade of triple-negative breast cancer, BREAST, 22巻, 5号, pp. 958-963, 201310
     DOIを用いた論文検索結果へのリンク
428. The prognostic role of pathologic invasive component size, excluding lepidic growth, in stage I lung adenocarcinoma, JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 146巻, 3号, pp. 580-585, 201309
     DOIを用いた論文検索結果へのリンク
429. Solid tumor size on high-resolution computed tomography and maximum standardized uptake on positron emission tomography for new clinical T descriptors with T1 lung adenocarcinoma, ANNALS OF ONCOLOGY, 24巻, 9号, pp. 2376-2381, 201309
     DOIを用いた論文検索結果へのリンク
430. Role of maximum standardized uptake value in fluorodeoxyglucose positron emission tomography/computed tomography predicts malignancy grade and prognosis of operable breast cancer: a multi-institute study, BREAST CANCER RESEARCH AND TREATMENT, 141巻, 2号, pp. 269-275, 201309
     DOIを用いた論文検索結果へのリンク
431. Treatment Outcomes and Prognostic Factors for Thoracic Esophageal Cancer with Clinical Evidence of Adjacent Organ Invasion, ANTICANCER RESEARCH, 33巻, 8号, pp. 3495-3502, 201308
     DOIを用いた論文検索結果へのリンク
432. Oncologic outcomes of segmentectomy compared with lobectomy for clinical stage IA lung adenocarcinoma: Propensity score-matched analysis in a multicenter study, JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 146巻, 2号, pp. 358-364, 201308
     DOIを用いた論文検索結果へのリンク
433. Radical Sublobar Resection for Small-Diameter Lung Cancers, THORACIC SURGERY CLINICS, 23巻, 3号, pp. 301-+, 201308
     DOIを用いた論文検索結果へのリンク
434. Solid tumors versus mixed tumors with a ground-glass opacity component in patients with clinical stage IA lung adenocarcinoma: Prognostic comparison using high-resolution computed tomography findings, JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 146巻, 1号, pp. 17-23, 201307
     DOIを用いた論文検索結果へのリンク
435. Decreased FANCJ caused by 5FU contributes to the increased sensitivity to oxaliplatin in gastric cancer cells, GASTRIC CANCER, 16巻, 3号, pp. 345-354, 201307
     DOIを用いた論文検索結果へのリンク
436. Involvement of ribonucleotide reductase-M1 in 5-fluorouracil-induced DNA damage in esophageal cancer cell lines, INTERNATIONAL JOURNAL OF ONCOLOGY, 42巻, 6号, pp. 1951-1960, 201306
     DOIを用いた論文検索結果へのリンク
437. A Feasibility Study of Induction Pemetrexed Plus Cisplatin Followed by Pleurectomy/Decortication Aimed at Macroscopic Complete Resection for Malignant Pleural Mesothelioma, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 43巻, 5号, pp. 575-578, 201305
     DOIを用いた論文検索結果へのリンク
438. Subtyping Lung Adenocarcinoma According to the Novel 2011 IASLC/ATS/ERS Classification Correlation with Patient Prognosis, THORACIC SURGERY CLINICS, 23巻, 2号, pp. 179-+, 201305
     DOIを用いた論文検索結果へのリンク
439. Airway Stenting for Tracheal Obstruction Due to Lymph Node Metastasis of Hepatocellular Carcinoma, ANTICANCER RESEARCH, 33巻, 4号, pp. 1761-1764, 201304
     DOIを用いた論文検索結果へのリンク
440. Prognostic significance of metabolic response by positron emission tomography after neoadjuvant chemotherapy for resectable malignant pleural mesothelioma, ANNALS OF ONCOLOGY, 24巻, 4号, pp. 1005-1010, 201304
     DOIを用いた論文検索結果へのリンク
441. Metabolomic analysis of dynamic response and drug resistance of gastric cancer cells to 5-fluorouracil, ONCOLOGY REPORTS, 29巻, 3号, pp. 925-931, 201303
     DOIを用いた論文検索結果へのリンク
442. Technical Feasibility and Cosmetic Advantage of Hybrid Endoscopy-Assisted Breast-Conserving Surgery for Breast Cancer Patients, JOURNAL OF LAPAROENDOSCOPIC & ADVANCED SURGICAL TECHNIQUES, 23巻, 2号, pp. 91-99, 201302
     DOIを用いた論文検索結果へのリンク
443. Leiomyosarcoma of the sigmoid colon with multiple liver metastases and gastric cancer: a case report, BMC GASTROENTEROLOGY, 12巻, 20120731
     DOIを用いた論文検索結果へのリンク
444. 食道の手術　食道亜全摘術・食道抜去術・下部食道切除術, プロフェッショナルがんナーシング, 2巻, 5号, pp. 532-37, 20120501
445. Upregulation of Notch2 and Six1 Is Associated with Progression of Early- Stage Lung Adenocarcinoma and a More Aggressive Phenotype at Advanced Stages, CLINICAL CANCER RESEARCH, 18巻, 4号, pp. 945-955, 20120215
     DOIを用いた論文検索結果へのリンク
446. 食道癌の術前治療　手術への影響は少ないが特有な有害事象への注意が必要, LiSA, 19巻, 2号, pp. 138-139, 20120201
447. 肺腺癌・扁平上皮癌におけるFDG-PETの予後因子としての意義, 広島医学, 65巻, 2号, pp. 72-77, 20120201
448. Krebs von den Lungen-6 (KL-6) is a prognostic biomarker in patients with surgically resected nonsmall cell lung cancer, INTERNATIONAL JOURNAL OF CANCER, 130巻, 2号, pp. 377-387, 20120115
     DOIを用いた論文検索結果へのリンク
449. Prediction of pathologic node-negative clinical stage IA lung adenocarcinoma for optimal candidates undergoing sublobar resection, JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 144巻, 6号, pp. 1365-1371, 201212
     DOIを用いた論文検索結果へのリンク
450. Protein expression and gene copy number changes of receptor tyrosine kinase in thymomas and thymic carcinomas, ANNALS OF ONCOLOGY, 23巻, 12号, pp. 3129-3137, 201212
     DOIを用いた論文検索結果へのリンク
451. Advanced esophageal cancer with an esophago-bronchial fistula successfully treated by chemoradiotherapy following esophageal bypass surgery: report of a case, SURGERY TODAY, 42巻, 11号, pp. 1088-1090, 201211
     DOIを用いた論文検索結果へのリンク
452. Non-small-cell lung cancer prognosis using carcinoembryonic antigen levels in pleural lavage fluid, EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 42巻, 5号, pp. E96-E101, 201211
     DOIを用いた論文検索結果へのリンク
453. Novel application for pseudopodia proteomics using excimer laser ablation and two-dimensional difference gel electrophoresis, LABORATORY INVESTIGATION, 92巻, 9号, pp. 1374-1385, 201209
     DOIを用いた論文検索結果へのリンク
454. Neoadjuvant chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil for esophageal cancer, CANCER CHEMOTHERAPY AND PHARMACOLOGY, 69巻, 6号, pp. 1499-1505, 201206
     DOIを用いた論文検索結果へのリンク
455. Airway Stenting for Malignant Respiratory Complications in Esophageal Cancer, ANTICANCER RESEARCH, 32巻, 5号, pp. 1785-1790, 201205
     DOIを用いた論文検索結果へのリンク
456. Laparoscopic Thoracic Duct Clipping for Persistent Chylothorax After Extrapleural Pneumonectomy, ANNALS OF THORACIC SURGERY, 93巻, 5号, pp. E131-E132, 201205
     DOIを用いた論文検索結果へのリンク
457. Fibrinogen/thrombin-based collagen fleece (TachoComb((R))) promotes regeneration in pulmonary arterial injury, EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 41巻, 4号, pp. 926-932, 201204
     DOIを用いた論文検索結果へのリンク
458. Esophageal reconstruction using the terminal ileum and right colon in esophageal cancer surgery, SURGERY TODAY, 42巻, 4号, pp. 342-350, 201204
     DOIを用いた論文検索結果へのリンク
459. Prognostic significance of using solid versus whole tumor size on high-resolution computed tomography for predicting pathologic malignant grade of tumors in clinical stage IA lung adenocarcinoma: A multicenter study, JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 143巻, 3号, pp. 607-612, 201203
     DOIを用いた論文検索結果へのリンク
460. Memorial Sloan-Kettering Cancer Center Nomogram to predict the risk of non-sentinel lymph node metastasis in Japanese breast cancer patients, SURGERY TODAY, 42巻, 3号, pp. 245-249, 201202
     DOIを用いた論文検索結果へのリンク
461. Radical hybrid video-assisted thoracic segmentectomy: long-term results of minimally invasive anatomical sublobar resection for treating lung cancer, INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 14巻, 1号, pp. 5-11, 201201
     DOIを用いた論文検索結果へのリンク
462. Interferon (Alpha, Beta and Omega) Receptor 2 Is a Prognostic Biomarker for Lung Cancer, PATHOBIOLOGY, 79巻, 1号, pp. 24-33, 2012
     DOIを用いた論文検索結果へのリンク
463. Cathepsin D as a potential prognostic marker for lung adenocarcinoma, PATHOLOGY RESEARCH AND PRACTICE, 208巻, 9号, pp. 534-540, 2012
     DOIを用いた論文検索結果へのリンク
464. A case of HER-2-positive recurrent breast cancer showing a clinically complete response to trastuzumab-containing chemotherapy after primary treatment of triple-negative breast cancer, WORLD JOURNAL OF SURGICAL ONCOLOGY, 9巻, 20111107
     DOIを用いた論文検索結果へのリンク
465. Steroid receptor expression in thymomas and thymic carcinomas., Cancer, 117巻, 19号, pp. 4396-4405, 20111001
466. Steroid Receptor Expression in Thymomas and Thymic Carcinomas, CANCER, 117巻, 19号, pp. 4396-4405, 20111001
     DOIを用いた論文検索結果へのリンク
467. Difference in prognostic significance of maximum standardized uptake value on [18F]-fluoro-2-deoxyglucose positron emission tomography between adenocarcinoma and squamous cell carcinoma of the lung., Jpn J Clin Oncol, 41巻, 7号, pp. 890-896, 20110701
468. Multicenter analysis of high-resolution computed tomography and positron emission tomography/computed tomography findings to choose therapeutic strategies for clinical stage IA lung adenocarcinoma., Jpn J Thorac Cardiovasc Surg, 141巻, 6号, pp. 1384-1391, 20110601
469. Advanced esophageal cancer with situs inversus totalis successfully treated with chemoradiotherapy followed by esophagectomy: case report, Hiroshima J Med Sci, 60巻, 1号, pp. 21-4, 20110601
470. Successful management of multiple esophagorespiratory fistulas using two types of stent: report of a case., Surg Today, 41巻, 4号, pp. 560-2, 20110401
471. Hybrid video-assisted thoracic surgery basilar (S9-10) segmentectomy., Semin Thorac Cardiovasc Surg, 23巻, 1号, pp. 73-77, 20110401
472. Advanced esophageal cancer with situs inversus totalis successfully treated with chemoradiotherapy followed by esophagectomy: case report., Hiroshima J Med Sci, 60巻, 1号, pp. 21-24, 20110301
473. Difference in Prognostic Significance of Maximum Standardized Uptake Value on [18F]-Fluoro-2-Deoxyglucose Positron Emission Tomography Between Adenocarcinoma and Squamous Cell Carcinoma of the Lung, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 41巻, 7号, pp. 890-896, 201107
     DOIを用いた論文検索結果へのリンク
474. Multicenter analysis of high-resolution computed tomography and positron emission tomography/computed tomography findings to choose therapeutic strategies for clinical stage IA lung adenocarcinoma, JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 141巻, 6号, pp. 1384-1391, 201106
     DOIを用いた論文検索結果へのリンク
475. Successful management of multiple esophagorespiratory fistulas using two types of stent: Report of a case, SURGERY TODAY, 41巻, 4号, pp. 560-562, 201104
     DOIを用いた論文検索結果へのリンク
476. Advantage of absorbable suture material for pulmonary artery ligation., Gen Thorac Cardiovasc Surg, 58巻, 10号, pp. 511-5, 20101001
477. Suggestive synchronous triple squamous cell carcinoma of the lung in the same lobe., Gen Thorac Cardiovasc Surg, 58巻, pp. 427-30, 20100801
478. Value of integrated positron emission tomography revised using a phantom to evaluate malignancy grade of lung adenocarcinoma: a multicenter study., Cancer, 111巻, pp. 3170-7, 20100701
479. 区域切除における区域間切離, 胸部外科 南光堂, 7月号増刊号63巻巻, 8号号, 20100701
480. Value of Integrated Positron Emission Tomography Revised Using a Phantom Study to Evaluate Malignancy Grade of Lung Adenocarcinoma A Multicenter Study, CANCER, 116巻, 13号, pp. 3170-3177, 20100701
     DOIを用いた論文検索結果へのリンク
481. Rapamycin enhances chemotherapy-induced cytotoxicity by inhibiting the expressions of TS and ERK in gastric cancer cells., Int J Cancer, 126巻, 11号, pp. 2716-25, 20100601
482. Impact of positive pleural lavage cytology on survival in patients having lung resection for non-small-cell lung cancer: An international individual patient data meta-analysis., J Thorac Cardiovasc Surg, 139巻, 6号, pp. 1441-6, 20100601
483. Impact of positive pleural lavage cytology on survival in patients having lung resection for non-small-cell lung cancer: An international individual patient data meta-analysis., Jpn J Thorac Cardiovasc Surg, 139巻, 6号, pp. 1441-6, 20100601
484. Rapamycin enhances chemotherapy-induced cytotoxicity by inhibiting the expressions of TS and ERK in gastric cancer cells, INTERNATIONAL JOURNAL OF CANCER, 126巻, 11号, pp. 2716-2725, 20100601
     DOIを用いた論文検索結果へのリンク
485. Surgical treatment of clinical N1 non-small cell lung cancer: ongoing controversy over diagnosis and prognosis., Surg Today, 40巻, 5号, pp. 428-32, 20100501
486. 区域切除術、部分切除術, 文光堂　呼吸器外科 Knack&Pitfalls, pp. 194-216, 20100501
487. A phase III randomized trial of lobectomy versus limited resection for small-sized peripheral non-small cell lung cancer (JCOG0802/WJOG4607L)., Jpn J Clin Oncol, 40巻, 3号, pp. 271-4, 20100301
488. 書評 [肺炎ガイドライン活用のための抗菌薬のかしこい使い方], 胸部外科 南光堂, 3月号63巻巻, 3号号, 20100301
489. 縮小手術　区域切除, 克誠堂出版　日本胸部臨床　増刊号　診療に役立つ「呼吸器疾患外科治療」のすべて, 3月号63巻巻, 3号号, 20100301
490. 再発形式と予後因子からみた食道癌に対する外科治療戦略, 癌の臨床, 56巻, 3号, pp. 213-218, 20100301
491. 高度進行胃癌に対するAdjuvant Surgeryの有用性に関する検討, 癌と化学療法, 37巻, 2号, pp. 263-266, 20100201
492. Phase I trial of oxaliplatin plus S-1 chemotherapy in patients with metastatic colorectal cancer., Oncol Lett, 1巻, 1号, pp. 95-98, 20100101
493. Surgical treatment of clinical N1 non-small cell lung cancer: Ongoing controversy over diagnosis and prognosis, SURGERY TODAY, 40巻, 5号, pp. 428-432, 201005
     DOIを用いた論文検索結果へのリンク
494. A Phase III Randomized Trial of Lobectomy Versus Limited Resection for Small-sized Peripheral Non-small Cell Lung Cancer (JCOG0802/WJOG4607L), JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 40巻, 3号, pp. 271-274, 201003
     DOIを用いた論文検索結果へのリンク
495. Phase I trial of oxaliplatin plus S-1 chemotherapy in patients with metastatic colorectal cancer, ONCOLOGY LETTERS, 1巻, 1号, pp. 95-98, 2010
     DOIを用いた論文検索結果へのリンク
496. Invited Commentary for Limited resection for noninvasive bronchioloalveolar carcinoma diagnosed by intraoperative pathologic examination., Ann Thorac Surg, 88巻, 4号, pp. 1111, 20091001
497. Short disease-free interval is a significant risk factor for intrapulmonary recurrence after resection of pulmonary metastases in colorectal cancer., Colorectal Dis, 12巻, (7 online)号, pp. e68-75, 20090701
498. Skin tube reconstruction for esophageal defect due to postoperative complication., Ann Thorac Surg, 87巻, pp. 1605-07, 20090501
499. CDDPとCPT-11併用化学療法が奏効したStage IVb食道小細胞癌の1例, 癌と化学療法, 36巻, 5号, pp. 831-4, 20090501
500. Skin tube reconstruction for esophageal defect due to postoperative complication, Ann Thorac Surg, 87巻, 5号, pp. 1605-7, 20090501
501. Possible involvement of regulatory T cells in tumor onset and progression in primary breast cancer, Cancer Immunol Immunother, 39巻, 3号, pp. 441-7, 20090301
502. A Feasibility Study of Induction Pemetrexed Plus Cisplatin Followed by Extrapleural Pneumonectomy and Postoperative Hemithoracic Radiation for Malignant Pleural Mesothelioma., Jpn J Clin Oncol, 39巻, 3号, pp. 186-8, 20090301
503. Induction of gamma delta T cells using zoledronate plus interleukin-2 in patients with metastatic cancer., Hiroshima J Med Sci, 58巻, 1号, pp. 37-44, 20090301
504. Targeting of CD4+CD25high cells while preserving CD4+CD25low cells with low-dose chimeric anti-CD2 antibody in adoptive immunotherapy of cancer., Int J Oncol, 34巻, 2号, pp. 563-72, 20090201
505. Invasive ductal carcinoma of the pancreas showing exophytic growth., Hepatobiliary Pancreat Dis Int, 8巻, 1号, pp. 97-102, 20090201
506. Targeting of CD4+CD25high cells while preserving CD4+CD25low cells with low-dose chimeric anti-CD25 antibody in adoptive immunotherapy of cancer, Int J Oncol, 34巻, 2号, pp. 563-72, 20090201
507. A Feasibility Study of Induction Pemetrexed Plus Cisplatin Followed by Extrapleural Pneumonectomy and Postoperative Hemithoracic Radiation for Malignant Pleural Mesothelioma, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 39巻, 3号, pp. 186-188, 200903
     DOIを用いた論文検索結果へのリンク
508. Possible involvement of regulatory T cells in tumor onset and progression in primary breast cancer, CANCER IMMUNOLOGY IMMUNOTHERAPY, 58巻, 3号, pp. 441-447, 200903
     DOIを用いた論文検索結果へのリンク
509. Targeting of CD4(+)CD25(high) cells while preserving CD4(+)CD25(low) cells with low-dose chimeric anti-CD25 antibody in adoptive immunotherapy of cancer, INTERNATIONAL JOURNAL OF ONCOLOGY, 34巻, 2号, pp. 563-572, 200902
     DOIを用いた論文検索結果へのリンク
510. Invasive ductal carcinoma of the pancreas showing exophytic growth, HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 8巻, 1号, pp. 97-102, 200902
     DOIを用いた論文検索結果へのリンク
511. Decreased orotate phosphoribosyltransferase activity produces 5-fluorouracil resistance in a human gastric cancer cell line., Oncol Rep, 20巻, 6号, pp. 1545-1551, 20081201
512. Expression of orotate phosphoribosyltransferase in colorectal carcinoma: an immunohistochemical analysis in several components of neoplastic lesions., Oncology Rep, 20巻, 5号, pp. 1005-1011, 20081101
513. Expression of orotate phosphoribosyltransferase in colorectal carcinoma: an immunohistochemical analysis in several components of neoplastic lesions, Oncol Rep, 20巻, 5号, pp. 1005-11, 20081101
514. A randomised phase II trial of preoperative chemotherapy of cisplatin-docetaxel or docetaxel alone for clinical stage IB/II non-small-cell lung cancer: results of a Japan Clinical Oncology Group trial (JCOG 0204), BRITISH JOURNAL OF CANCER, 99巻, 6号, pp. 852-857, 20080909
     DOIを用いた論文検索結果へのリンク
515. A randomised phase II trial of preoperative chemotherapy of cisplatin-docetaxel or docetaxel alone for clinical stage IB/II non-small-cell lung cancer results of a Japan Clinical Oncology Group trial (JCOG 0204)., Br J Cancer, 99巻, 6号, 20080901
516. Dihydropyrimidine dehydrogenase and orotate phosphoribosyltransferase in esophageal cancer patients: Correlation with clinicopathological factors and prognosis, Mol Med Report, 1巻, 5号, pp. 713-9, 20080901
517. A feasibility study of postoperative adjuvant therapy of carboplatin and weekly paclitaxel for completely resected non-small cell lung cancer., J Thorac Oncol., 3巻, 6号, pp. 612-616, 20080601
518. Expression of cell adhesion molecule 1 in malignant pleural mesothelioma as a cause of efficient adhesion and growth on mesothelium., Lab Invest., 88巻, 5号, pp. 504-514, 20080501
519. Dose-finding study of anti-CD25 antibody for targeting regulatory T cells in locoregional immunotherapy of malignant effusion., Hiroshima J Med Sci., 57巻, 1号, pp. 37-46, 20080501
520. Radical sublobar resection for lung cancer., Gen Thorac Cardiovasc Surg., 56巻, 4号, pp. 151-7, 20080401
521. Radical surgery for malignant pleural mesothelioma: results and prognosis., Interact Cardiovasc Thorac Surg., 7巻, 1号, pp. 102-106, 20080201
522. Regulatory T細胞の制御と癌免疫療法, Biotherapy, 22巻, 1号, pp. 29-34, 20080101
523. Decreased orotate phosphoribosyltransferase activity produces 5-fluorouracil resistance in a human gastric cancer cell line, ONCOLOGY REPORTS, 20巻, 6号, pp. 1545-1551, 200812
     DOIを用いた論文検索結果へのリンク
524. Expression of orotate phosphoribosyltransferase in colorectal carcinoma: An immunohistochemical analysis in several components of neoplastic lesions, ONCOLOGY REPORTS, 20巻, 5号, pp. 1005-1011, 200811
     DOIを用いた論文検索結果へのリンク
525. Functional inactivation of CD4+CD25(high) regulatory T cells using low dose human/mouse chimeric anti-CD25 monoclonal antibody enhanced lymphokine-activated killer cells activity, TARGETED ONCOLOGY, 3巻, 4号, pp. 227-234, 200810
     DOIを用いた論文検索結果へのリンク
526. A feasibility study of postoperative adjuvant therapy of carboplatin and weekly paclitaxel for completely resected non-small cell lung cancer, JOURNAL OF THORACIC ONCOLOGY, 3巻, 6号, pp. 612-616, 200806
     DOIを用いた論文検索結果へのリンク
527. Expression of cell adhesion molecule 1 in malignant pleural mesothelioma as a cause of efficient adhesion and growth on mesothelium, LABORATORY INVESTIGATION, 88巻, 5号, pp. 504-514, 200805
     DOIを用いた論文検索結果へのリンク
528. Dihydropyrimidine dehydrogenase and orotate phosphoribosyltransferase in esophageal cancer patients: Correlation with clinicopathological factors and prognosis, MOLECULAR MEDICINE REPORTS, 1巻, 5号, pp. 713-719, 2008
     DOIを用いた論文検索結果へのリンク
529. イマチニブの術前投与により縮小手術が可能になった十二指腸GISTの1例, 日本臨床外科学会雑誌, 68巻, 9号, pp. 2248-52, 20070901
530. Pleomorphic carcinoma of the lung., Jpn J Thorac Cardiovasc Surg, 134巻, pp. 399-404, 20070801
531. 胸膜中皮腫の外科的治療法の進歩―胸膜肺全摘術の有用性について, 最新医学　アスベストによる健康障害, 62巻, 1号, pp. 81-85, 20070401
532. 自然気胸, 看護のための疾患・症候辞典, 20070401
533. 間質性肺炎患者の肺癌手術, 呼吸　―基礎肺疾患を有する患者の肺癌手術の周術期医療, 26巻, 2号, pp. 161-164, 20070401
534. 悪性胸膜中皮腫の治療：外科治療の適応, MOOK「肺癌の臨床」2006-2007, 20070401
535. 肺癌の拡大手術, 医学のあゆみ　呼吸器疾患―start of arts―, 20070401
536. 縮小手術の方法・適応および利点と欠点, 呼吸器コモンディズィーズの診療―肺癌のすべて―, pp. 262-263, 20070401
537. 再発癌、二次肺癌に対する外科治療, 呼吸器コモンディズィーズの診療―肺癌のすべて―, pp. 268-270, 20070401
538. 肺癌肺転移　外科的な立場, 日本胸部臨床　転移性肺腫瘍へのアプローチ, 20070401
539. 外科治療, Medical Science Digest　中皮腫の最新情報, 20070401
540. 肺癌：手術：超高齢者の手術は, EBM呼吸器疾患の治療2008-2009, 20070401
541. Associations among bronchioloalveolar carcinoma component, positron emission tomographic, computed tomographic findings and malignant behavior in small lung adenocarcinomas, J. Thorac Cardiovasc Surg, 20070401
542. A novel video-assisted anatomical segmentectomy technique-Selective segmental inflation via bronchofiberoptic jet followed by cautery cutting-, J. Thorac Cardiovasc Surg, 133巻, pp. 753-758, 20070401
543. Novel marker D2-40, combined with calretinin, CEA and TTF-1: An optimal set of immunodiagnostic markers for pleural mesothelioma, Cancer, 109巻, 5号, pp. 933-938, 20070401
544. Novel marker D2-40, combined with calretinin, CEA and TTF-1: An optimal set of immunodiagnostic markers for pleural mesothelioma., Cancer, 109巻, 5号, pp. 933-938, 20070301
545. Pleomorphic carcinoma of the lung: A surgical outcome, JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 134巻, 2号, pp. 399-404, 200708
     DOIを用いた論文検索結果へのリンク
546. Associations among bronchioloalveolar carcinoma components, positron emission tomographic and computed tomographic findings, and malignant behavior in small lung adenocarcinomas, JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 133巻, 6号, pp. 1448-1454, 200706
     DOIを用いた論文検索結果へのリンク
547. Radical sublobar resection for small-sized non-small cell lung cancer: A multicenter study, J. Thorac Cardiovasc Surg, 132巻, pp. 769-775, 20060401
548. Selective mediastinal lymphadenectomy for clinico-surgical stage I non-small cell lung cancer, Ann Thorac Surg, 81巻, pp. 1028-1032, 20060401
549. Carbon monoxide rescues ischemic lungs by interrupting MAPK-driven expression of early growth response 1 gene and its downstream target genes., Proc. Natl. Acad. Sci. USA, 103巻, 13号, pp. 5191-5196, 20060401
550. Bronchoplasty for bronchial carcinoid tumor without removing lung parenchyma., Jpn J Thorac Cardiovasc Surg, 54巻, 8号, pp. 345-347, 20060401
551. 小型肺がんに対する区域切除, Annual Review 呼吸器 2003, pp. 238-243, 20060401
552. 低侵襲手術による肺区域切除, 胸部外科　７月増刊号, 59巻, 8号, pp. 724-729, 20060401
553. 中皮腫トピックス　外科療法, 日本胸部臨床, 65巻, 7号, pp. 646-650, 20060401
554. 気管支形成術を駆使した肺癌手術, Medical Torch, 12巻, 3号, pp. 18-19, 20060401
555. 非小細胞肺癌の治療　切除可能肺癌, 日本胸部臨床 肺癌up-to-date-, 65巻, 増刊Ｓ号, pp. 143-148, 20060401
556. 肺癌に対する胸腔鏡下手術Hybrid VATSの適応と限界, 最新医学　肺癌治療ー新たな治療体系の確立と展開ー, 61巻, 11号, pp. 2246-2252, 20060401
557. Carbon monoxide rescues ischemic lung by interrupting MAPK-driven expression of early growth response 1 gene and its downstream target genes., Proceedings of the National Academy of Sciences of the United States of America, 103巻, 13号, pp. 5191-5196, 20060328
558. Hybrid surgical approach of video-assisted minithoracotomy for lung cancer -Significance of direct visualization on quality of surgery-, Chest, 128巻, 4号, pp. 2629-2701, 20050401
559. Border between N1 and N2 stations in lung carcinoma: Lessons from lymph node metastatic patterns of lower lobe tumors, J. Thorac Cardiovasc Surg, 129巻, 4号, pp. 825-830, 20050401
560. Effect of tumor size on prognosis in non-small cell lung cancer:The role of segmentectomy as a type of lesser resection, J. Thorac Cardiovasc Surg, 129巻, 1号, pp. 87-93, 20050401
561. Influence of ischemic injury on vein graft remodeling: Role of cyclic adenosine monophosphate second messenger pathway in enhanced vein graft preservation, J. Thorac Cardiovasc Surg, 129巻, pp. 129-137, 20050401
562. Increased expression of connexin 26 in the invasive component of lung squamous cell carcinoma: Significant correlation with poor prognosis, Cancer lett., 234巻, pp. 239-248, 20050401
563. Functional advantage following radical segmentectomy over lobectomy for lung cancer, Ann Thorac Surg, 80巻, 6号, pp. 2041-2045, 20050401
564. Complications and outcomes after pulmonary resection for cancer in patients 80 to 89 years of age., Eur J Cardiothorac Surg, 28巻, 3号, pp. 380-383, 20050401
565. 肺癌拡大区域切除の成績と適応, 日本外科学会雑誌, 106巻, 6号, pp. 395-399, 20050401
566. 増え続ける肺癌/治療成績を向上させるために　末梢小型肺癌に対するアプローチ, 外科治療, 93巻, 4号, pp. 421-426, 20050401
567. 肺癌の治療2005-2007　胸膜中皮腫の外科治療, コンセンサス癌治療, 4巻, 4号, pp. 228-229, 20050401
568. 呼吸器外科手術の基礎知識　肺癌に対する拡大手術, 呼吸器ケア, 3巻, 6号, pp. 77-81, 20050401
569. ミニ開胸（VATS）による区域切除, 肺癌, 45巻, 3号, pp. 261-266, 20050401
570. Sleeve segmentectomy for non-small cell lung carcinoma, J. Thorac Cardiovasc Surg, 128巻, 3号, pp. 420-424, 20040401
571. Effect of histologic type and smoking status on the interpretation of serum carcinoembryonic antigen value in non-small cell lung carcinoma, Ann Thorac Surg, 78巻, pp. 1004-1009, 20040401
572. Prognostic significance of perioperative serum carcinoembryonic antigen in non-small cell lung cancer:　Analysis of 1,000 consecutive resections for clinical stage I disease, Ann Thorac Surg, 78巻, pp. 216-221, 20040401
573. Evolution of surgical outcomes for non-small cell lung cancer:Time trends in 1465 consecutive patients subjected to a complete resection, Ann Thorac Surg, 77巻, pp. 1926-1930, 20040401
574. Correlation between computed tomographic findings, bronchioloalveolar carcinoma component and the biologic behavior of small-sized lung adenocarcinomas, J. Thorac Cardiovasc Surg, 127巻, pp. 857-861, 20040401
575. Cloning of a soluble isoform of the SgIGSF adhesion molecule that binds the extracellular domain of the membrane-bound isoform, Oncogene, 23巻, pp. 5687-5692, 20040401
576. Management of Air Leak after Pulmonary Resection, Jpn J Thorac Cardiovasc Surg, 52巻, pp. 292-295, 20040401
577. PKCbeta regulates ischemia/reperfusion injury in the lung, J. Clin. Invest., 113巻, pp. 1615-1623, 20040401
578. Resection of chest wall invasion in patients with non-small cell lung cancer, Eur J Cardiothorac Surg, 26巻, 6号, pp. 1200-1204, 20040401
579. 胸部外科および境界疾患の最新治療/悪性胸膜中皮腫に対する外科的役割, 日本胸部外科学会卒後セミナー誌, pp. 240-248, 20040401
580. PKCbeta regulates ischemia/reperfusion injury in the lung., The Journal of clinical investigation, 113巻, 11号, pp. 1615-1623, 200406
581. Discrepancy of computed tomographic image between lung and mediastinal windows as a prognostic implication in small lung adenocarcinoma, Ann Thorac Surg, 76巻, pp. 1828-1832, 20030401
582. Characteristics and prognosis of patients after resection of non-small cell lung carcinoma measuring 2 cm or less in greatest dimension, Cancer, 98巻, 3号, pp. 535-541, 20030401
583. Pleural lavage cytology in non-small cell lung cancer: Lessons from 1,000 consecutive resections, J. Thorac Cardiovasc Surg, 126巻, 6号, pp. 1911-1915, 20030401
584. Long-term survival and prognostic factors of 5-year survivorswith complete resection of non-small cell lung carcinoma, J. Thorac Cardiovasc Surg, 126巻, 2号, pp. 558-562, 20030401
585. Clinical implication and prognostic significance of the tumor-suppressor TSLC1 gene detected in adenocarcinomas of the lung, Cancer, 98巻, pp. 1002-1007, 20030401
586. Expression of the TSLC1 Adhesion Molecule in Pulmonary Epithelium and its Downregulation in Pulmonary　Adenocarcinoma other than Bronchioloalveolar Carcinoma, Lab.Invest., 83巻, pp. 1175-1183, 20030401
587. Peroxisome proliferator-activated receptor-{gamma} (PPAR-{gamma}) activation suppresses ischemic induction of Egr-1 and its inflammatory gene targets, FASEB J., 16巻, 14号, pp. 1861-1868, 20020401
588. Transcriptional Control of Cardiac Allograft Vasculopathy by Early Growth Response Gene-1 (Egr-1), Circ Res, 91巻, 2号, pp. 135-142, 20020401
589. Extinguishing Egr-1-dependent inflammatory and thrombotic cascades after lung transplantation, FASEB J., 15巻, 14号, pp. 2757-2759, 20010401
590. Is segmentectomy with lymph node assessment an alternative to lobectomy for non-small cell lung cancer of 2 cm or smaller ?, Ann Thorac Surg, 71巻, 3号, pp. 956-960, 20010401
591. Survival related to lymph node involvement in lung cancer after sleeve lobectomy compared with pneumonectomy, J. Thorac Cardiovasc Surg, 119巻, pp. 814-819, 20000401
592. Induction therapy for non-small cell lung cancer with involved mediastinal nodes in multiple stations, Chest, 118巻, 1号, pp. 123-128, 20000401
593. Surgical Treatment for Chronic Pleural Empyema, Surg Today, 30巻, 6号, pp. 506-510, 20000401
594. Multiple Primary Lung Carcinomas : Letter to Editor (Reply), J. Thorac Cardiovasc Surg, 119巻, 4号, pp. 814-819, 20000401
595. A role for heterologous gap junctions between melanoma and endothelial cells in metastasis, J. Clin. Invest., 105巻, pp. 1189-1197, 20000401
596. A role for heterologous gap junctions between melanoma and endothelial cells in metastasis., The Journal of clinical investigation, 105巻, 9号, pp. 1189-1197, 200005
597. Extended sleeve lobectomy for lung cancer: the avoidance of pneumonectomy, J. Thorac Cardiovasc Surg, 118巻, 4号, pp. 710-713, 19990401
598. How should interlobar pleural invasion be classified? Prognosis of resected T3 non-small cell lung cancer?, Ann Thorac Surg, 68巻, 6号, pp. 2049-2052, 19990401
599. Multiple Primary Lung Carcinomas : Letter to Editor (Reply), J. Thorac Cardiovasc Surg, 117巻, 2号, pp. 405-406, 19990401
600. Evaluation of TNM Classification for Lung Carcinoma with Ipsilateral Intrapulmonary Metastasis, Ann Thorac Surg, 68巻, 2号, pp. 326-330, 19990401
601. Prognosis of Completely Resected pN2 Non-Small Cell Lung Carcinomas: What is the Significant Node that Affects Survival?, J. Thorac Cardiovasc Surg, 118巻, 2号, pp. 270-275, 19990401
602. Right Upper and Middle Sleeve Bilobectomy with Atypical Pulmonary Arterioplasty, Ann Thorac Cardiovase Surg, 47巻, pp. 121-123, 19990401
603. Role of Pleural Lavage Cytology Before Resection for Primary Lung Carcinoma, Ann Surg, 229巻, 4号, pp. 579-584, 19990401
604. Usefulness of cardiopulmonary bypass in reconstruction of inferior vena cava occupied by renal cell carcinoma tumor thrombus, Angiology, 50巻, pp. 47-53, 19990401
605. Proposal for Reasonable Mediastinal Lymphadenectomy in Bronchogenic Carcinomas: Role of Subcarinal Nodes in Selective Dissection, J. Thorac Cardiovasc Surg, 116巻, 6号, pp. 949-953, 19980401
606. Two cases of synchronous multiple thymoma, Surg Today, 28巻, pp. 1323-1325, 19980401
607. Operative Approach for Multiple Primary Lung Carcinomas, J. Thorac Cardiovasc Surg, 115巻, 4号, pp. 836-840, 19980401
608. Omentopexy for anastomotic dehiscence after tracheal sleeve pneumonectomy, Thorac Cardiovasc Surgeon, 45巻, 3号, pp. 144-145, 19970401
609. Single Lung Transplantation for Canine Pulmonary Hypertension, J. Heart Lung Transplant., 16巻, 5号, pp. 532-537, 19970401
610. Sleeve lobectomy for lung carcinoma in a patient with muscular dystrophy, Thorac Cardiovasc Surgeon, 44巻, 5号, pp. 264-265, 19960401
611. Right ventricular ejection fraction in the preoperative risk evaluation of candidates for pulmonary resection, J. Thorac Cardiovasc Surg, 112巻, pp. 364-370, 19960401
612. Efficacy of oxygenated University of Wisconsin solution containing endothelin-A receptor antagonist in twenty-four-hour heart preservation, J. Heart Lung Transplant., 15巻, pp. 475-484, 19960401
613. Contribution of Endothelin-1 to Warm Ischemia/Reperfusion Injury of the Rat Lung, Am J Respir Crit Care Med, 152巻, 6号, pp. 2105-2110, 19950401
614. Establishment Canine Pulmonary Hypertension with Dehydromonocrotaline: Importance of a Larger Animal Model for Lung Transplantation, Transplantation, 60巻, 1号, pp. 9-13, 19950401
615. Role of Endothelin-1 in Beagles with Dehydromonocrotaline-Induced Pulmonary Hypertension, Circulation, 92巻, 1号, pp. 114-119, 19950401
616. Endothelin Receptor Antagonists in a Beagle Model of Pulmonary Hypertension. Contribution to Possible Potential Therapy?, J Am Coll Cardiol, 25巻, 5号, pp. 1213-1217, 19950401
617. A Dehydromonocrotaline-induced Pulmonary Hypertension Model in the Beagle., J. Thorac Cardiovasc Surg, 110巻, 2号, pp. 546-547, 19950401
618. ★, Simultaneous patch closure of an atrial septal defect and pancreaticoduodenectomy for chronic pancreatitis., Eur J Surg, 161巻, 4号, pp. 295-297, 19950401
619. Successful 24-hour rabbit heart preservation by hypothermic continuous coronary microperfusion with oxygenated University of Wisconsin Solution, Ann Thorac Surg, 60巻, pp. 1723-1728, 19950401
620. ★, Right ventricular dysfunction after major pulmonary resection, J. Thorac Cardiovasc Surg, 108巻, 3号, pp. 503-511, 19940401
621. ★, Cervicothoracic vagal neurilemoma, Surgery Today, 24巻, 2号, pp. 183-186, 19940401
622. ★, Simultaneous occurrence of three primary lung cancers, Chest, 105巻, 2号, pp. 631-632, 19940401
623. ★, The unusual development of empyema with multiple alveolobronchiolar fistulae 8 years after non-curative resection and radiation for lung cancer, Surgery Today, 23巻, 12号, pp. 1085-1088, 19930401
624. Successful resection of a recurrent leiomyosarcoma of the pulmonary trunk, Ann Thorac Surg, 55巻, pp. 1009-1012, 19930401
625. Randomized phase II trial of pemetrexed-cisplatin plus bevacizumab or thoracic radiotherapy followed by surgery for stage IIIA (N2) nonsquamous non-small cell lung cancer., J Thorac Cardiovasc Surg, 20211209
626. Pathological high malignant grade is higher risk of recurrence in pN0M0 invasive lung adenocarcinoma, even with small invasive size., Thorac Cancer, 20211012
627. Reply to "Lobe-Specific Lymph Node Dissection for Lung Cancer: Is It Still Feasible?" by Han-Yu Deng., Ann Surg Oncol, 20211009
628. Risk of death due to other causes is lower among octogenarians with non-small cell lung cancer after wedge resection than lobectomy/segmentectomy., Jpn J Clin Oncol, 20211005
629. Prognostic Impact of Mediastinal Lymph Node Dissection in Octogenarians With Lung Cancer: JACS1303., Clin Lung Cancer, 20210924
630. ASO Author Reflections: Survival Outcomes between Patients with Hypermetabolic Non-small Cell Lung Cancer Undergoing Systematic and Lobe-Specific Mediastinal Lymph Node Dissection., Ann Surg Oncol, 20210903
631. Clinicopathologic Features and Response to Therapy of NRG1 Fusion-Driven Lung Cancers: The eNRGy1 Global Multicenter Registry., J Clin Oncol, 20210901
632. Bevacizumab plus erlotinib versus erlotinib alone in Japanese patients with advanced, metastatic, EGFR-mutant non-small-cell lung cancer (NEJ026): overall survival analysis of an open-label, randomised, multicentre, phase 3 trial., Lancet Respir Med, 20210826
633. Parallel-Group Controlled Trial of Surgery Versus Chemoradiotherapy in Patients With Stage I Esophageal Squamous Cell Carcinoma., Gastroenterology, 20210810
634. ASO Author Reflection: Position of the Complex Segmentectomy on Postoperative Pulmonary Function., Ann Surg Oncol, 20210723
635. Postoperative Pulmonary Function After Complex Segmentectomy., Ann Surg Oncol, 20210722
636. Neoadjuvant pemetrexed plus cisplatin followed by pleurectomy for malignant pleural mesothelioma., J Thorac Cardiovasc Surg, 20210717
637. Ultrasonography Combined With Contrast-enhanced Ultrasonography Can Predict Lymphocyte-predominant Breast Cancer., Cancer Diagn Progn, 20210703
638. Systematic Versus Lobe-Specific Mediastinal Lymphadenectomy for Hypermetabolic Lung Cancer., Ann Surg Oncol, 20210703
639. Complete Response for Advanced Hepatocellular Carcinoma by Conversion Surgery Therapy Following a Good Response of Regorafenib Despite Rapid Progressive Disease with Sorafenib., Intern Med, 20210701
640. Adjuvant Chemotherapy for High-risk Pathologic Stage I Non-Small Cell Lung Cancer., Ann Thorac Surg, 20210626
641. Role of Soluble Receptor for Advanced Glycation End Products in Postoperative Fibrotic Lung Injury., Ann Thorac Surg, 20210615
642. Identification of High-Risk of Recurrence in Clinical Stage I Non-Small Cell Lung Cancer., Front Oncol, 20210607
643. Serum S100 calcium-binding protein A4 as a novel predictive marker of acute exacerbation of interstitial pneumonia after surgery for lung cancer., BMC Pulm Med, 20210602
644. Prognostic role of interstitial pneumonia with or without emphysema in patients with clinical stage I lung cancer., Jpn J Clin Oncol, 20210601
645. The impact of pathological lymph node metastasis with lymphatic invasion on the survival of patients with clinically node-negative non-small cell lung cancer: A multicenter study., Lung Cancer, 20210529
646. Effect of Wnt5a on drug resistance in estrogen receptor-positive breast cancer., Breast Cancer, 20210528
647. ASO Author Reflections: Is Wedge Resection Optimal for Octogenarians with Early-Stage Non-Small-Cell Lung Cancer Compared with Lobectomy/Segmentectomy?, Ann Surg Oncol, 20210523
648. Clinical effect of the pathological axillary assessment method in breast cancer without clinical nodal metastasis., Breast Cancer, 20210519
649. A risk model for prolonged air leak after lobectomy using the National Clinical Database in Japan., Surg Today, 20210517
650. Predictive role of circulatory HMGB1 in postoperative acute exacerbation of interstitial lung disease in lung cancer patients., Sci Rep, 20210512
651. Phase 2 Study of YS110, a Recombinant Humanized Anti-CD26 Monoclonal Antibody, in Japanese Patients With Advanced Malignant Pleural Mesothelioma., JTO Clin Res Rep, 20210429
652. Segmentectomy for STAS positive lung adenocarcinoma., Ann Thorac Surg, 20210429
653. Reply to Zhang et al., Eur J Cardiothorac Surg, 20210429
654. Japanese Current Status of Curative-Intent Surgery for Malignant Pleural Mesothelioma., Ann Thorac Surg, 20210427
655. Phase II Study of Neoadjuvant Concurrent Chemo-immuno-radiation Therapy Followed by Surgery and Adjuvant Immunotherapy for Resectable Stage IIIA-B (Discrete N2) Non-small-cell Lung Cancer: SQUAT trial (WJOG 12119L)., Clin Lung Cancer, 20210427
656. Survival of Octogenarians with Early-Stage Non-small Cell Lung Cancer is Comparable Between Wedge Resection and Lobectomy/Segmentectomy: JACS1303., Ann Surg Oncol, 20210426
657. Transition of Treatment for Ground Glass Opacity-Dominant Non-Small Cell Lung Cancer., Front Oncol, 20210415
658. Meta-analysis of nanoparticle albumin-bound paclitaxel used as neoadjuvant chemotherapy for operable breast cancer based on individual patient data (JBCRG-S01 study)., Breast Cancer, 20210403
659. Meta-analysis of nanoparticle albumin-bound paclitaxel used as neoadjuvant chemotherapy for operable breast cancer based on individual patient data (JBCRG-S01 study)., Breast Cancer, 28巻, 5号, pp. 1023-1037, 20210403
660. Prediction of the tumor response and survival based on computed tomography in esophageal squamous cell carcinoma after trimodality therapy., Surg Today, 20210402
661. Prediction of the tumor response and survival based on computed tomography in esophageal squamous cell carcinoma after trimodality therapy., Surg Today, 20210402
662. Comprehensive analysis of the clinicopathological features, targetable profile, and prognosis of mucinous adenocarcinoma of the lung., J Cancer Res Clin Oncol, 20210401
663. CheckMate 577 Investigators.Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer, N Engl J Med, 20210401
664. Comprehensive analysis of the clinicopathological features, targetable profile, and prognosis of mucinous adenocarcinoma of the lung., J Cancer Res Clin Oncol, 20210401
665. Preoperative nivolumab to evaluate pathological response in patients with stage I non-small cell lung cancer: a study protocol of phase II trial (POTENTIAL)., BMJ Open, 20210317
666. Breast cancer detection by dedicated breast positron emission tomography according to the World Health Organization classification of breast tumors., Eur J Surg Oncol, 20210303
667. Surgical challenges in multimodal treatment of N2-stage IIIA non-small cell lung cancer., Jpn J Clin Oncol, 20210303
668. Appropriate Extent of Lymphadenectomy in Segmentectomy: A Multicenter Study., Jpn J Clin Oncol, 20210303
669. Bronchial mucosal ablation for bronchial stump closure in right pneumonectomy: a case report., J Med Case Rep, 20210218
670. Certified thoracic surgeons in Japan: a national database survey on risk-adjusted mortality associated with lung resection., Surg Today, 20210130
671. Performance of dedicated breast positron emission tomography in the detection of small and low-grade breast cancer., Breast Cancer Res Treat, 20210123
672. A phase II study of cisplatin plus vinorelbine combined with atezolizumab as adjuvant therapy for completely resected non-small-cell lung cancer with EGFR mutation (West Japan Oncology Group 11719L/ADJUST study)., Ther Adv Med Oncol, 20210121
673. Salvage surgery for non-small cell lung cancer after tyrosine kinase inhibitor treatment., Lung Cancer, 20210110
674. Long-term results of definitive chemoradiotherapy for unresectable locally advanced esophageal squamous cell carcinoma., J Radiat Res, 20210101
675. Recent advances and future perspectives in adjuvant and neoadjuvant immunotherapies for lung cancer., Jpn J Clin Oncol, 20210101
676. Recent advances and future perspectives in adjuvant and neoadjuvant immunotherapies for lung cancer., Jpn J Clin Oncol, 20210101
677. Long-term results of definitive chemoradiotherapy for unresectable locally advanced esophageal squamous cell carcinoma., J Radiat Res, 20210101
678. Clinical Efficacy and Safety of Nivolumab in Japanese Patients With Malignant Pleural Mesothelioma: 3-Year Results of the MERIT Study., JTO Clin Res Rep, 20201229
679. Prediction of Unexpected N2 Disease Associated With Clinical T1-2N0-1M0 Non-Small-Cell Lung Cancer., Clin Lung Cancer, 20201227
680. Utility of Newly Proposed Grading System From International Association for the Study of Lung Cancer for Invasive Lung Adenocarcinoma., JTO Clin Res Rep, 20201126
681. Salvage Surgery for Non-Small Cell Lung Cancer After Definitive Radiotherapy., Ann Thorac Surg, 20201126
682. Salvage surgery for non-small-cell lung cancer after definitive radiotherapy., Ann Thorac Surg, 20201126
683. Surgical Procedure Selection for Stage I Lung Cancer: Complex Segmentectomy versus Wedge Resection., Clin Lung Cancer, 20201117
684. Surgical Procedure Selection for Stage I Lung Cancer: Complex Segmentectomy versus Wedge Resection., Clin Lung Cancer., 20201117
685. Nivolumab versus chemotherapy in Japanese patients with advanced esophageal squamous cell carcinoma: a subgroup analysis of a multicenter, randomized, open-label, phase 3 trial (ATTRACTION-3)., Esophagus, 20201110
686. Febrile neutropenia and role of prophylactic granulocyte colony-stimulating factor in docetaxel and cyclophosphamide chemotherapy for breast cancer., Support Care Cancer, 20201104
687. Segmentectomy vs Lobectomy for Clinical Stage IA Lung Adenocarcinoma With Spread Through Air Spaces., Ann Thorac Surg, 20201102
688. Comparison of cancer control between segmentectomy and wedge resection in patients with clinical stage IA non-small cell lung cancer., J Thorac Cardiovasc Surg, 20201022
689. Prediction of Acute Exacerbation of Interstitial Pneumonia Using Visual Evaluation of PET., Ann Thorac Surg, 20201012
690. ASO Author Reflections: Usefulness of Visual Evaluation of PET in Predicting Prognosis after Lung Resection for Early-Stage Lung Adenocarcinoma and Selecting Candidates for Sublobar Resection., Ann Surg Oncol, 20200923
691. Patient Selection of Sublobar Resection Using Visual Evaluation of Positron-Emission Tomography (PET) for Early-Stage Lung Adenocarcinoma., Ann Surg Oncol, 20200918
692. Distribution of Lymph Node Metastasis in Esophageal Squamous Cell Carcinoma After Trimodal Therapy., Ann Surg Oncol, 20200903
693. Oncologic Outcomes of Complex Segmentectomy: A Multicenter Propensity Score-Matched Analysis., Ann Thorac Surg, 20200812
694. Commentary: Aspects of epidermal growth factor receptor status: Prognostic factor versus predictive factor., J Thorac Cardiovasc Surg, 20200803
695. Long-Term Outcomes After Sublobar Resection Versus Lobectomy in Patients With Clinical Stage IA Lung Adenocarcinoma Meeting the Node-Negative Criteria Defined by High-Resolution Computed Tomography and [18F]-Fluoro-2-Deoxy-d-Glucose Positron Emission Tomography., Clin Lung Cancer, 20200619
696. Novel technique for identification of the pulmonary intersegmental plane using manual jet ventilation during pulmonary segmentectomy., Wideochir Inne Tech Maloinwazyjne, 20200601
697. Differences in immune response to anesthetics used for day surgery versus hospitalization surgery for breast cancer patients., Clinical and translational medicine, 201709
698. Outcomes after lobar versus sublobar resection for clinical stage I non-small cell lung cancer in patients with interstitial lung disease., The Journal of thoracic and cardiovascular surgery, 154巻, 3号, pp. 1089-1096, 201709
699. Gene expression profiling of idiopathic interstitial pneumonias (IIPs): identification of potential diagnostic markers and therapeutic targets., BMC medical genetics, 201708
700. Does the histologic predominance of pathological stage IA lung adenocarcinoma influence the extent of resection?, General thoracic and cardiovascular surgery, 201706

著書等出版物

1. 2011年07月, Digestive Surgery Now 14 吻合術と縫合術, メジカルビュー社, 2011年, 07, 単行本（学術書）, 共編著
2. 呼吸器外科の手術看護パーフェクトマニュアル, メディカ出, 岡田守人編集, 9784840453417
3. 呼吸器外科の術前術後ケア : ナースのためのパーフェクトガイド, メディカ出, 岡田守人編, 9784840446150
4. イラストで学ぶ系統的肺区域切除術区切アトラス, 文光, 野守裕明, 岡田守人著, 9784830623356
5. 2016年04月, 呼吸器外科テキスト（オンラインアクセス権付）－外科専門医・呼吸器外科専門医をめざす人のために, 共著, 978-4-524-25858-1
6. 2006年07月, Hybrid VATSによる根治的縮小切除, 胸部外科 = The Japanese journal of thoracic surgery, 岡田 守人

招待講演、口頭・ポスター発表等

1. シンポジウム「小型肺癌に対する外科治療」, 岡田 守人, 第30回日本呼吸器内視鏡学会学術集会, 2008年, 招待, 日本語
2. 特別講演「悪性胸膜中皮腫―治療戦略―」, 岡田 守人, 第60回日本後部外科学会定期学術集会, 2008年, 招待, 日本語
3. 特別講演「肺癌手術における血管の処理方法とステープラー選択」, 岡田 守人, 第48回日本肺癌学会総会, 2008年, 招待, 日本語
4. 特別講演「肺癌・大腸癌の縮小手術を考える」, 岡田 守人, 第107回日本外科学会総会, 2008年, 招待, 日本語
5. 特別講演「Hybrid VATSによる根治的区域切除」, 岡田 守人, 第24回日本呼吸器外科学会総会, 2008年, 招待, 日本語
6. 特別講演「肺癌診療におけるピットホール」, 岡田 守人, 第24回日本呼吸器外科学会総会, 2008年, 招待, 日本語
7. 特別講演「肺癌に対する機能温存手術」, 岡田 守人, 第50回関西胸部外科学会学術集会, 2008年, 招待, 日本語
8. 特別講演「根治的縮小手術選択における画像診断の役割」, 岡田 守人, 第60回日本胸部外科学会定期学術集会, 2008年, 招待, 日本語
9. シンポジウム「悪性胸膜中皮腫に対する根治的治療」, 岡田 守人, 第55回日本職業災害医学会学術大会, 2008年, 招待, 日本語
10. シンポジウム「Consensus and Controversy for Practice」, 岡田 守人, 第48回日本肺癌学会総会, 2008年, 招待, 日本語

受賞

1. 2008年, 第1回日本呼吸器外科学会賞

外部資金

競争的資金等の採択状況

1. 革新的がん医療実用化研究事業, 臨床病期I/II期非小細胞肺癌におけるリンパ節郭清の縮小化の治療的意義を検証するランダム化比較試験, 2023年/4月/1日, 2024年/3月/3日
2. 革新的がん医療実用化研究事業, 特発性肺線維症（IPF）合併臨床病期I期非小細胞肺癌に対する肺縮小手術に関するランダム化比較第III相試験, 2023年/4月/1日, 2024年/3月/3日
3. 革新的がん医療実用化研究事業, 非浸潤または小型非小細胞肺がんに対する機能温存手術の確立に関する研究, 2023年/4月/1日, 2024年/3月/3日
4. 革新的がん医療実用化研究事業, 臨床病期I/II期非小細胞肺癌におけるリンパ節郭清の縮小化の治療的意義を検証するランダム化比較試験, 2022年/0月4/日, 2023年/0月3/日
5. 革新的がん医療実用化研究事業, 特発性肺線維症（IPF）合併臨床病期I期非小細胞肺癌に対する肺縮小手術に関するランダム化比較第III相試験, 2022年/0月4/日, 2023年/0月3/日
6. 革新的がん医療実用化研究事業, 非浸潤または小型非小細胞肺がんに対する機能温存手術の確立に関する研究, 2022年/0月4/日, 2023年/0月3/日
7. 革新的がん医療実用化研究事業, 臨床病期I/II/III食道癌（T4を除く）に対する胸腔鏡下手術と開胸手術のランダム化比較第III相試験, 2022年/0月4/日, 2023年/0月3/日
8. 革新的がん医療実用化研究事業, 臨床病期Ⅰ/Ⅱ期非小細胞肺癌におけるリンパ節郭清の縮小化の治療的意義を検証するランダム化比較試験, 2021年04月01日, 2022年03月31日
9. 革新的がん医療実用化研究事業, 特発性肺線維症（IPF）合併臨床病期I期非小細胞肺癌に対する肺縮小手術に関するランダム化比較第III相試験, 2021年04月01日, 2022年03月31日
10. 革新的がん医療実用化研究事業, 臨床病期I/II/III食道癌（T4を除く）に対する胸腔鏡下手術と開胸手術のランダム化比較第III相試験, 2021年04月01日, 2022年03月31日
11. 革新的がん医療実用化研究事業, 非浸潤または小型非小細胞肺がんに対する機能温存手術の確立に関する研究, 2021年04月01日, 2022年03月31日
12. 革新的がん医療実用化研究事業, 施設からの症例登録・経過報告, 2015年04月01日, 2016年03月31日
13. 科学研究費助成事業(挑戦的萌芽研究), 肺気腫発生・進展の新規メカニズムの解明：その発症・重症化の予防と新規治療薬の開発, 2014年, 2015年
    関連URL
14. 科学研究費助成事業(挑戦的萌芽研究), 浸潤突起を選択的に採取できる新技術レーザープロテオミクスによる肺癌浸潤機構の解明, 2012年, 2013年
    関連URL
15. 科学研究費助成事業(基盤研究(C)), DNA損傷修復蛋白を分子標的とした食道癌に対する新規化学放射線療法の開発, 2010年, 2012年
    関連URL
16. 科学研究費助成事業(基盤研究(B)), 小型肺腺癌における悪性化を規定する新規遺伝子の網羅的解析, 2009年, 2011年
    関連URL
17. 厚生労働科学研究, 非浸潤または小型非小細胞肺癌に対する標準的機能温存手術の確立に関する研究, 2014年05月01日, 2015年03月31日
18. 科学研究費助成事業(基盤研究(C)), microRNA制御を応用した新しい食道癌化学放射線療法の開発, 2013年, 2015年
    関連URL
19. 科学研究費助成事業(基盤研究(C)), メタボローム解析による悪性胸膜中皮腫細胞の低酸素応答機構の解明, 2013年, 2015年
    関連URL
20. 科学研究費助成事業(基盤研究(B)), 肺胞上皮癌における浸潤性肺腺癌への悪性化進展メカニズムの解明, 2012年, 2014年
    関連URL
21. 科学研究費助成事業(基盤研究(C)), ＳＡＧＥ法による新たな消化器癌幹細胞特異的遺伝子の同定とその機能解析, 2012年, 2014年
    関連URL
22. 科学研究費助成事業(基盤研究(C)), リアルタイム細胞分子動態解析法による肺がんの低酸素バイオロジーの解明, 2010年, 2012年
    関連URL
23. 科学研究費助成事業(挑戦的萌芽研究), ビデオマススコープによるEGFR遺伝子変異の単一細胞レベル超高感度検出法の開発, 2010年, 2011年
    関連URL
24. 科学研究費助成事業(基盤研究(C)), Immune checkpointを標的としたHER2乳癌に対する薬物療法の開発, 2015年, 2018年
25. 科学研究費助成事業(基盤研究(C)), DNA修復阻害による合成致死性を応用した新たな食道癌化学放射線療法の開発, 2015年, 2018年
26. 革新的がん医療実用化研究事業, 施設からの症例登録・経過報告, 2016年04月01日, 2017年03月31日
27. 革新的がん医療実用化研究事業, 非浸潤または小型非小細胞肺がんに対する機能温存手術の確立に関する研究, 2017年04月01日, 2018年03月31日
28. 革新的がん医療実用化研究事業, 臨床病期Ⅰ/Ⅱ期非小細胞肺癌におけるリンパ節郭清の縮小化の治療的意義を検証するランダム化比較試験, 2017年04月01日, 2018年03月31日
29. 革新的がん医療実用化研究事業, 非浸潤または小型非小細胞肺がんに対する機能温存手術の確立に関する研究, 2018年04月01日, 2019年03月31日
30. 革新的がん医療実用化研究事業, 臨床病期Ⅰ/Ⅱ期非小細胞肺癌におけるリンパ節郭清の縮小化の治療的意義を検証するランダム化比較試験, 2018年04月01日, 2019年03月31日
31. 科学研究費助成事業(挑戦的研究(萌芽)), 肺癌診療でのCT検査の安全性を探るハイスループット放射線被曝評価法の開発, 2018年, 2019年
32. 革新的がん医療実用化研究事業, 非浸潤または小型非小細胞肺がんに対する機能温存手術の確立に関する研究, 2019年04月01日, 2020年03月31日
33. 革新的がん医療実用化研究事業, 臨床病期Ⅰ/Ⅱ期非小細胞肺癌におけるリンパ節郭清の縮小化の治療的意義を検証するランダム化比較試験, 2019年04月01日, 2020年03月31日
34. 革新的がん医療実用化研究事業, 臨床病期Ⅰ/Ⅱ期非小細胞肺癌におけるリンパ節郭清の縮小化の治療的意義を検証するランダム化比較試験, 2020年04月01日, 2021年03月31日
35. 革新的がん医療実用化研究事業, 特発性肺線維症（IPF）合併臨床病期I期非小細胞肺癌に対する肺縮小手術に関するランダム化比較第III相試験, 2020年04月01日, 2021年03月31日
36. 革新的がん医療実用化研究事業, 非浸潤または小型非小細胞肺がんに対する機能温存手術の確立に関する研究, 2020年04月01日, 2021年03月31日
37. 革新的がん医療実用化研究事業, 臨床病期I/II/III食道癌（T4を除く）に対する胸腔鏡下手術と開胸手術のランダム化比較第III相試験, 2020年04月01日, 2021年03月31日

社会活動

委員会等委員歴

1. がん対策専門委員会委員, 2015年05月, 2017年03月, 広島県地域保健対策協議会
2. 非常勤医師, 2015年04月, 2016年03月, （医）社団ひろまさ会
3. 非常勤医師, 2015年04月, 2016年03月, （医）社団曙会
4. 非常勤医師, 2015年04月, 2016年03月, 三原市医師会病院
5. 高精度放射線治療ｾﾝﾀｰ(仮称)整備推進委員会臓器別検討会議委員, 2014年07月, 2015年03月, 広島県
6. 非常勤医師, 2014年04月, 2015年03月, （医）社団ひろまさ会
7. 非常勤医師, 2014年04月, 2015年03月, （医）社団曙会
8. 非常勤医師, 2014年04月, 2015年03月, 三原市医師会病院
9. 非常勤医師, 2013年04月, 2014年03月, （医）社団ひろまさ会
10. 非常勤医師, 2013年04月, 2014年03月, （医）社団曙会
11. 非常勤医師, 2013年04月, 2014年03月, 三原市医師会病院

その他社会貢献活動（広大・部局主催含）

1. セカンドオピニオン（肺癌治療）, 情報提供
2. 国立がんセンター、広島県及び県内のがん診療連携拠点病院を中心としたがん医療への取り組みや、最近のがん医療についての講演・情報提供。（講演内容：肺がんの診療の最前線）, 広島大学病院（地域連携室）, 2007年, 2007年
3. 呼吸器外科手術におけるドレナージについて, ジョンソン・エンド・ジョンソン株式会社, 「呼吸器外科手術におけるドレナージを考える会」, 2009年/01月, 2009年/01月
4. 肺癌の診断・治療に関する最新の知見を提供、癌診療の充実を目指して, アストラゼネカ株式会社, 「第4回呼吸器外科肺癌診断治療会」, 2009年/02月, 2009年/02月, その他
5. 「術中出血とその対応」, コヴィディエンジャパン, 「第2回General Thoracic Surgical Forum」, 2009年/02月, 2009年/02月
6. 食道癌治療について, エーザイ株式会社, 「第19回広島食道疾患懇話会」, 2009年/02月, 2009年/02月
7. 肺癌治療について, 大鵬薬品工業株式会社, 「肺癌セミナー」, 2009年/03月, 2009年/03月
8. 肺癌治療について, ジョンソン・エンド・ジョンソン株式会社, 「第1回肺を想う会」, 2009年/03月, 2009年/03月, その他
9. 肺癌治療について, 田辺三菱製薬株式会社, 「第5回札幌胸部外科フォーラム」, 2009年/04月, 2009年/04月, その他
10. 「PET/CTは肺癌診療に貢献できるのか？」, 日本メジフィジックス株式会社, 「第109回日本外科学会定期学術集会ランチョンセミナー」, 2009年/04月, 2009年/04月, 学術団体
11. 肺癌治療について, 化学及血清療法研究所, 「呼吸器外科先進フォーラム」, 2009年/04月, 2009年/04月
12. 「がん患者の痛みに対する啓発と早期疼痛治療の必要性および導入方法の改善」, ヤンセンファーマ株式会社, 「Cancer Pain Management Workshop 2009 in 広島」, 2009年/04月, 2009年/04月, その他
13. 肺癌治療について, ジョンソン・エンド・ジョンソン株式会社, 「第5回アジア胸部外科研究会ランチョンセミナー」, 2009年/04月, 2009年/04月, その他
14. 「肺癌手術の基礎」, ジョンソン・エンド・ジョンソン株式会社, 「基礎から学ぶ肺癌手術セミナー2009 Vol.1」, 2009年/05月, 2009年/05月, その他
15. 「肺癌手術の基礎」, ジョンソン・エンド・ジョンソン株式会社, 「基礎から学ぶ肺癌手術セミナー2009 Vol.1」, 2009年/05月, 2009年/05月, その他
16. 肺癌治療について, 大鵬薬品工業株式会社, 「呉内視鏡外科研究会」, 2009年/05月, 2009年/05月
17. 肺癌治療について, 田辺三菱製薬株式会社, 「胸部外科セミナー」, 2009年/07月, 2009年/07月
18. 「最新の肺癌治療」, 株式会社ツムラ, 「山県郡医師会学術講演会」, 2009年/06月, 2009年/06月
19. 肺癌治療について, 小野薬品工業株式会社, 「Thoracic Perioperative Care Seminar 2009」, 2009年/06月, 2009年/06月, その他
20. 肺癌治療について, ジョンソン・エンド・ジョンソン株式会社, 「呼吸器セミナー」, 2009年/06月, 2009年/06月, その他
21. 「最新の肺癌治療」, ヤンセンファーマ株式会社, 「第60回備北地区学術講演会」, 2009年/07月, 2009年/07月, その他
22. 肺癌治療について, CSLベーリング株式会社, 「第1回広島呼吸器外科研究会」, 2009年/06月, 2009年/06月
23. 乳癌治療について, 中外製薬株式会社, 「広島乳がん外来治療研究会」, 2009年/07月, 2009年/07月, その他
24. 「中皮腫対策臨床試験について」, 株式会社中国放送, RCC夕方情報番組「イブニングふぉー」, 2007年/11月, 2007年/11月, 社会人・一般
25. 「左肺上葉切除術」, タイコヘルスケアジャパン, 「General Thoracic Surgical Forum」, 2008年/02月, 2008年/02月
26. 「区域切除」, タイコヘルスケアジャパン, 「General Thoracic Surgical Forum」, 2008年/02月, 2008年/02月
27. 肺癌の診断・治療に関する最新の知見を提供し、癌診療の充実を図る, アストラゼネカ株式会社, 「第3回呼吸器外科肺癌診断治療会」, 2008年/02月, 2008年/02月, その他
28. 「Hybrid VATS」, ジョンソン・エンド・ジョンソン株式会社, 「7th Technical Seminar in Thoracic Surgery」, 2008年/02月, 2008年/02月, その他
29. 肺癌治療について, 大鵬薬品工業株式会社, 「三原市医師会学術講演会」, 2008年/03月, 2008年/03月
30. 「肺漏予防に対する工夫」「低侵襲アプローチと手術の質」, CSLベーリング株式会社, 「北海道呼吸器外科懇談会」, 2008年/03月, 2008年/03月
31. 「肺癌手術の最前線」, 中外製薬株式会社, 「第11回長崎手術手技研究会」, 2008年/03月, 2008年/03月, その他
32. 「各種疾患の最新医療に関する検討および情報・意見交換会」, 大鵬薬品工業株式会社, 「第22回人吉・球磨最新医療研究会」, 2008年/03月, 2008年/03月, その他
33. 肺癌治療について, 広島肺癌補助療法グループ　ブリストル・マイヤーズ株式会社, 「広島呼吸器外科カンファレンス」, 2007年/04月, 2007年/04月, その他
34. 「肺癌・胸膜中皮腫に対する最新治療」, 広島市佐伯区医師会, 広島市佐伯区医師会講演会, 2007年/06月, 2007年/06月, その他
35. 肺癌治療について, 広島中部地区臨床外科談話会　武田薬品工業株式会社, 「第１１会広島中部地区臨床外科談話会」, 2007年/09月, 2007年/09月
36. 肺癌治療について, ホワイト会（ユノ川クリニック・温泉川梅代）, 「ホワイト会講演会」, 2007年/11月, 2007年/11月
37. 「肺癌診療の最先端」, 帝京もみじ会　日本新薬株式会社, 「第６回帝京もみじ会学術講演会」, 2007年/10月, 2007年/10月
38. 「最近の肺癌診療」, 世羅郡医師会, 「世羅郡医師会学術講演会」, 2007年/10月, 2007年/10月, その他
39. 「肺癌治療におけるHRCTとPET－CTの役割」, エーザイ株式会社, 「第２３回岡山胸部画像病理カンファレンス」, 2007年/09月, 2007年/09月, その他
40. 「肺癌の手術と術前・術後療法」, ブリストル・マイヤーズ株式会社, 「肺癌治療セミナー」, 2007年/09月, 2007年/09月
41. 肺癌の最新情報の提供, 日本イーライリリー株式会社, 「広島胸部悪性腫瘍講演会」, 2007年/09月, 2007年/09月, その他
42. 肺癌治療について, 山口県肺癌研究会事務局　日本化薬株式会社　グラクソ・スミスクライン株式会社, 「第２４回山口県肺癌研究会」, 2007年/10月, 2007年/10月
43. 肺癌のPET検査における画像診断の臨床的意義と読影のノウハウをつたえる, 株式会社メディカルトリビューン, 「肺癌診断におけるPET検査を含めた画像診断の役割と今後の展望」, 2007年/08月, 2007年/08月
44. 「肺癌外科治療の最前線」, 熊本呼吸器縦隔疾患研究会　塩野義製薬株式会社, 「第３回熊本呼吸器・縦隔疾患研究会」, 2007年/08月, 2007年/08月, その他
45. 肺癌治療について, OLCSG　大鵬薬品工業株式会社, 「肺癌学術講演会」, 2007年/08月, 2007年/08月
46. 「肺癌治療の最前線」, 広島市南区医師会　大鵬薬品工業株式会社, 「広島市南区医師会教育講演会」, 2007年/07月, 2007年/07月
47. 「最新の肺がん外科治療」, 広島市内科医会　ファイザー株式会社, 「第４６６回広島市内科医会」, 2007年/08月, 2007年/08月
48. 「呼吸器外科における解剖・術式と臨床医から見た児童縫合器のより安全な使用法」, ジョンソン・エンド・ジョンソン株式会社, 「第１回中国四国地区呼吸器外科（VATS）社内勉強会」, 2007年/07月, 2007年/07月, 企業
49. 「肺癌治療の現在と未来」, 広島県国民健康保険診療施設協議会　広島県国民健康保険団体連合会, 「第３３回広島県国保診療施設地域医療学会」, 2007年/08月, 2007年/08月
50. 肺癌の化学療法について, 協和発酵工業株式会社, 「協和発酵工業（株）中国支店広島第一営業所社員教育講演指導, 2007年/06月, 2007年/06月, 企業

学術雑誌論文査読歴

1. 編集員
2. 編集員